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1  Motivation and Objective 
 
Invention of the phase contrast microscope in 1930 resulting in the award of the 
Nobel Prize in Physic to Frits Zernike [1], forefronted the development of a plethora of 
sophisticated microscope techniques that have now revolutionized the way in which 
the invisible becomes visible. Ever since the very first cellular structure was pictured, 
scientists have been fascinated by the investigation of the dynamic processes in 
living organism. The living cell is not a regular subject; in fact they contain the most 
complicated functions and complex systems. In order to develop a better 
understanding of the biological processes using microscopic techniques, some 
requirements should be considered; (I) the sensitivity of the detection, (II) the speed 
of acquisition and (III) the viability of the specimen. In addition, it is crucial to consider 
the cell’s health during the imaging process which means not only staying alive but 
also to remain in a metabolic state with no nonspecific changes. Hence, the 
development of the visualized techniques has increased in number over the last 
decade. The fluorescence-based imaging technique has shown to be greatly 
beneficial over other techniques [2]. Live cell fluorescent imaging employs the 
naturally fluorophore (fluorescent proteins) or synthetically attaches to biomolecules 
(organic fluorescent dyes) with respect not to interfere with biological systems. The 
discovery of the naturally occurring green fluorescent protein (GFP) in the early 20th 
century, by the following who were awarded the Noble Prize in Chemistry in 2008; 
Osamu Shimomura, Martin Chalfie, and Roger Tsien [3], revolutionized live cell 
imaging. Since then, the numerous applications have been reported. The fluorescent 
proteins (FPs) are considered as nontoxic compounds to cells. However, due to their 
large size, applications are limited. Recent studies found that the organic 
fluorophores have provided to be of great benefit to investigate biological processes 
where the small size of fluorescent probes are required [4]. Regarding the labeling 
process occurring inside cells, it is crucial that the small size of fluorophores do not 
alter the natural behavior of the molecule, are nontoxic and react selectively with the 
introduced target molecule under physiological conditions. The conjugation of the 
fluorescent marker with the reactive partner inside cells has been intensively 
investigated to date, since the first discovery of bioorthogonal chemistry strategies 
were reported in 2008 by the group of Bertozzi [5]. Bioorthogonal reactions are most 
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promising for evaluating live cell imaging with the advantage of the fluorescence 
properties of the fluorophore which can be manipulated by the simple chemical 
reaction and while reaction rate can be tuned by the selection of reactive partners 
towards the requirement. The ligation between azides and strained alkynes, so called 
Strain-Promoted Azide-Alkyne Cycloaddition (SPAAC), is the most promising method 
for probing live organisms. The advantages of this strategy are its reaction with 
exceptional reaction rate (k  2.4-4000  10-3 M-1s-1) without employing any metal 
catalyst [6] and proceeding smoothly under physiological conditions (37 C, aqueous 
media or cells lysate) (Figure 1).  
 
 
 
 
 
 
Figure 1 Bioorthogonal conjugation of reactive functionalized biomolecules in the presence of an 
abundance biocompatible functional groups.  
 
In this thesis Strain-Promoted Azide-Alkyne cycloaddition reaction (SPAAC) of 
reactive cyclooctyne- and triazine-modified oligonucleotides with fluorescent dyes will 
be investigated by both pre- and postsynthetic labeling manners. The SPAAC is a 
powerful tool for evaluating complex biological processes [7]. This is because of the 
smooth conjugation when performing under physiological conditions (37 C, aqueous 
media or cells lysate), without employing metal catalysts (“copper-free click” reaction) 
or using high temperatures and a high selectivity towards their reaction partners in 
the presence of an abundance of nucleophilic groups (in living cells). In addition, the 
reaction rate constant can be tuned by simple chemical reactions to offer a reaction 
rate (k  2.4-4000  10-3 M-1s-1) which is compatible with biological processes [6]. In 
order to investigate the capability of structurally simple reactive compounds as 
biological markers, the carboxymonobenzocyclooctyne (COMBO) 7 and the 3-
carboxy-1,2,4-triazine moieties 32 will be attached to position 5 of 
37 C, pH = 7 
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2’-deoxyuridine. The corresponding building blocks can be incorporated into DNA via 
chemical DNA synthesis (by the advances of phosphoramidite method) (Figure 2) or 
enzymatic DNA synthesis by the use of polymerases (primer extension of 
unprotected base-modified 2’-deoxyuridine triphosphates) (Figure 3). The 
corresponding base-modified DNA will further be conjugated with the corresponding 
reaction partners in both in vitro and in vivo experiments.  
 
 
 
Figure 2 Strain-promoted reaction of cyclooctyne-modified DNA with azide-modified fluorescent dye 
21b in vitro and in vivo experiments. 
 
The incorporation of base-modified nucleoside triphosphates using a polymerase has 
more advantages over solid-phase DNA synthesis, as the defined incorporation of 
different building blocks into one strand is possible by replacing the natural 
triphosphate monomers. Also many of different strands can be synthesized via 
selection of the template strand, and long-stranded DNA/RNA can be synthesized 
(10 kb - 70 kb) [8] without a significant decrease in its efficiency. Moreover, it is 
applicable for sensitive moieties which are not able to withstand the harsh conditions 
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of solid-phase synthesis. In this approach, the base-modified 2’-deoxyuridine 
triphosphate building blocks 24 and 35 will be singly and multiply incorporated into 
DNA and subsequently conjugated with their reactive partner.  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 3 Enzymatic DNA synthesis (primer extension experiment) of base-modified nucleoside 
triphosphates. The extension product will further be ligated with fluorescent dyes under physiological 
conditions. 
 
 
 
DNA polymerase,  
3 natural dNTPs 
3’ 
5’ 
5’ 
3’ 
5’ 
3’ 
dUTP 
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reaction 
5’ 
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3’ 
5’ 
3’ 
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2 Theoretical background 
 
2.1 Bioorthogonal Chemistry 
 
Bioconjugation is the process of linking two or more reactive compounds, at least one 
of them being a biomolecule, under physiological conditions. The term bioorthogonal 
chemistry was originally coined by Bertozzi [5]. It denoted that “it neither interacts with 
nor interferes with a biological system”. Additionally, the participating functional 
groups must conjugate with high chemo-selectivity towards biocompatible conditions, 
minimally perturbing the biological system into which it has been introduced and 
being nontoxic to the living cell (Figure 4). 
 
 
 
 
 
 
Figure 4 A general bioorthogonal conjugation of reactive functionalized biomolecules in the presence 
of an abundance biocompatible functional groups.  
 
The very first example of a bioorthogonal reaction was demonstrated by Rideout and 
co-workers. The condensation of hydrazine and an aldehyde could be selectively 
harnessed to assemble toxins from inactive prodrugs within living cells [9]. In the late 
1990s, Tsien and co-workers reported the first example of live cell protein labeling by 
using bisarsenical dyes [10]. Since then various bioorthogonal reactions have been 
intensively investigated and demonstrated as an instrument for biological discovery 
and biotechnology, allowing for selective and controlled introduction of labels [11]. The 
various bioorthogonal ligation strategies are not only applicable for protein labeling 
but also on cell surface, in living cells and even in live animal. Including ketones and 
37 C, pH = 7 
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aldehydes [12], azides (Staudinger ligation [13], Copper-Catalyzed Azide-Alkyne 
Cycloaddition [14] and Strain-Promoted Azide-Alkyne Cycloaddition [15]), nitrones [16], 
nitrile oxides [17], diazo compounds [18], alkenes [19] (Electron demand Diels-Alder 
reaction), tetrazines [20] (Inverse electron demand Diels-Alder reaction) and tetrazoles 
[20e, 21] (“Photoclick” reaction). Although, considerable research on bioconjugation has 
been demonstrated and can be utilized for studying biological processes, only few 
examples were reported in the field of nucleic acids [7c, 22].  
 
2.2 Bioorthogonal reactions 
 
2.2.1  Copper-Catalyzed Azide-Alkyne Cycloaddition (CuAAC) 
 
In the middle of 20th century Huisgen reported the first synthesis of 1,2,3-triazole from 
1,3-dipolar cycloaddition reaction of diethyl acetylenedicarboxylate and phenyl azide 
to provide a mixture of 1,4- and 1,5-disubstitution products [23]. Despite the reaction 
providing a high yield and selective control of the regioselectivity by the introduction 
of steric hindrance of substituents on substrates and the polarity of solvent, a high 
temperature is needed (100 C) [24] and is proceeded with a low reaction rate [25]. It 
was Sharpless and Meldal who independently discovered the use of copper to 
catalyze the ligation reaction of an alkyne and an azide to increase the reaction rate 
constant (may increase up to 7 orders of magnitude regarding uncatalyzed version, k 
 10-200 M-1s-1) as well as the regioselectivity (only 1,4-triazole is formed) [26]. Since 
then the numerous applications of CuAAC have been reported in various fields such 
as polymer and material science [27], drug discovery [26a, 28], chemical biology [29] and 
bio-imaging [14c]. The most attractive benefit of using CuAAC as a bioorthogonal tool 
are (I) neither azide nor terminal alkyne functional groups can be attached to 
oligonucleoside building blocks therefore allows the incorporation into DNA via 
automated solid-phase synthesis with high efficiency, (II) tolerance of a broad range 
of functional groups which can be applied in in vivo when a variety of reactive 
functional groups are present and (III) significant increase in reaction rate with 
respect to the uncatalyzed version and smooth proceeding under physiological 
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conditions to form regioselective 1,4-disubstituted triazole products. However, the 
major drawback of the use of CuAAC is that copper ions are highly toxic which 
causes DNA damage, typically yielding strand breaks [30], causing cell death, 
preventing cell division, and killing small organisms (zebrafish embryos) [31]. Thus, 
introducing of suitable ligands like tris(benzyl)triazolymethyl amine (TBTA) and their 
water soluble derivatives tris(hydroxypropyl)triazolylmethyl amine (THPTA) can 
overcome this problematic issue [32] (Scheme 1). 
 
 
 
Scheme 1 The ligation reaction of terminal alkynes and azides: A) Huisgen 1,3-dipolar cycloaddition, 
B) Copper-Catalyzes Azide-Alkyne Cycloaddition. 
 
Since then a significant increase in the number of applications using the CuAAC 
reaction as a novel methodology to label and modify DNA have been reported [33]. 
Oligonucleotides can be labeled with reactive functional groups via two strategies, so 
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called presynthetic and postsynthetic labeling (Figure 5). Presynthetic labeling 
signifies that the nucleoside monomer carries the desired label before DNA 
synthesis. However, the major drawback of this strategy is that phosphoramidites 
bearing the desired moieties need to be stable enough to survive the harsh 
conditions employed during automated solid phase synthesis (acidic, alkaline and 
oxidative condition). An alternative method to label the DNA of interest is the so 
called postsynthetic labeling, which denotes that the modification process occurs 
after completion of DNA synthesis [29a]. Sensitive or reactive moieties can be coupled 
with the DNA of interest without any critical conjugation steps needed. Moreover, 
changing to another label does not require a challenging nucleotide synthesis. 
According to these advantages, a wide range of biomolecules has been labeled to 
date, including proteins [34], polysaccharides [35], peptides [36] and even living cells [37]. 
 
 
 
 
 
 
Figure 5 Schematic representation for presynthesis; A) blue: nucleotides, red: markers) and 
postsynthesis, B) blue: nucleotides, green: reactive functional groups, red: marker). 
 
 
A) 
B) 
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Recently, the modification of nucleoside building blocks as biological markers has 
gained more interest of scientists in the fields of chemical biology and bioimaging. 
Azide or alkyne functional groups have been introduced into oligonucleoside 
monomers either at 5-position for pyrimidines and 7-position for 7-deazapurines or 
the sugar backbone at 2’-position in the ribofuranoside unit. It is noteworthy that the 
azide-modified building blocks are intrinsically difficult to incorporate into DNA via 
solid-phase chemistry, as azides are prone to be reduced by the phosphorus (III) 
atom of phosphoramidites. These limitations prohibit the accessible incorporation of 
azide-modified DNA via solid-phase DNA synthesis. The very first example of azido-
modified on oligonucleotide was reported by the group of Wagenknecht and co-
workers [38]. 5-Iodo-2’-deoxyuridine was introduced into oligonucleotides via solid-
phase synthesis with further in situ nucleophilic substitution by NaN3. The 
corresponding azide-modified DNA was further conjugated with a compatible 
fluorescent dye (Scheme 2). Another method was reported by the group of Micura 
[39]. They proposed a novel synthetic method for phosphodiester building blocks of 2’-
azido-modified nucleosides which allows efficient site-specific incorporation into RNA 
by using standard solid-phase RNA synthesis.  
 
 
 
Scheme 2 Copper-Catalyzed Azide-Alkyne Cycloaddition of azide-modified oligonucleotides with 
fluorescent probes for bioorthogonal labeling. 
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Regarding the critical step which is needed for the modification of azide moieties on 
nucleosides, alkyne-modified nucleoside building blocks were chosen as alternative 
component. Carell et al. reported the modification of alkyne-modified DNA at C5 of  
2’-deoxyuridine as a reactive partner towards azido-fluorescent probes [40]. The high-
density labeled DNA was then coupled with azide fluorescent markers, in particular 
coumarin azides, azido-sugar and fluorescein azides as a strong fluorescent label for 
use in biophysical applications [41] (Scheme 3). The group of Seela and co-workers 
introduced long chain linkers into C5 of pyrimidine and C7 of purine in particular, 
propynyl and octadiynyl residues which showed a positive influence on the duplex 
stability by increasing the thermal stability by 2-3 C per modification, in comparison 
to unmodified nucleotide strand [42] (Scheme 3). An alternative position is at 2’-
ribofuranoside, Wagenknecht et al., reported the utilization of CuAAC tool for 
postsynthetic fluorescent labeling of DNA by incorporation of 2’-propargyluridine into 
DNA via solid-phase synthesis which is further conjugated with fluorescent coumarin 
dyes [43]. Later studies demonstrated that the configuration of the 2’-propargyl-
modified uridine plays an important role in improving the fluorescence and energy 
transfer properties. The 2’-propargyl-modified arabino-configured uridine was 
introduced into DNA using phosphoramidite method and conjugated with a set of 
photostable cyanine-styryl dyes for the FRET pairs in DNA duplex which can be 
applied for two-color read out in both in vitro and in vivo [44]. Independently, the group 
of Floris L. van Delft proposed acetylene modified adenosines as versatile building 
blocks for a variety of oligonucleotide hetero- and homoconjugates [30]. The alkyne-
modified oligonucleotide was linked via [3+2] cycloaddition with azido-fluorescent 
dyes under mild and efficient reaction conditions. These make the variation of alkyne-
modified nucleoside building blocks crucial for the bioconjugation applications. 
 
11 
 
 
 
Scheme 3 Alkyne-modified oligonucleotides for bioorthogonal “click” reaction to azido-fluorescent 
markers. 
 
In spite of the fact that numerous applications of CuAAC were reported, the use of 
highly toxic copper catalyst has limited the capability to evaluate biological systems. 
Regarding the toxicity issue, there are intensively investigated alternative methods, 
so called metal-free catalyzed cycloaddition reaction including the “Photoclick” 
reaction, Diels-Alder (DA), Inverse electron demand Diels-Alder reaction (iEDDA) and 
Strain-Promoted Azide-Alkyne Cycloaddition (SPAAC), in particular.  
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2.2.2 Diel-Alder reaction (DA) and Inverse electron demand Diels-Alder 
reaction (iEDDA) 
 
The Diels-Alder reaction is defined by a [4+2] cycloaddition between a 4 electron 
system (a diene) with a 2 electron system (a dienophile) to form a new 
stereospecific six-membered ring product [45]. The Diels-Alder reaction is controlled 
by the energy gap between the highest occupied molecular orbital (HOMO) and the 
lowest unoccupied molecular orbital (LUMO) of the substrates. The reaction rate can 
be enhanced by lowering the HOMO-LUMO energy gap of the substrates by either 
introducing electron-withdrawing groups or electron-donating groups on substrates or 
increase the ring strain of the system. The DA can be classified as normal electron-
demand (HOMO-diene) or inverse electron-demand (LUMO-diene) based on the 
frontier molecular orbitals which take part. The most commonly employed dienophile 
for the normal electron-demand Diel-Alder reaction (DA) are maleimide derivatives 
(electron-poor alkenes) [46]. These reactive alkenes react smoothly with various 
conjugated dienes however, due to the high reactivity; it spontaneously reacts with 
an abundance of nucleophiles occurring in living organisms. The group of Howorka 
reported the use of DA for DNA labeling, where the diene-modified deoxyuridine was 
incorporated into DNA via primer extension experiment and subsequently conjugated 
with a maleimide-modified fluorescent dye [47] (Scheme 4). 
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Scheme 4 The Diels-Alder reaction between diene-modified DNA and a set of maleimide-modified 
fluorescent dyes. 
 
The latter reaction type is the Inverse electron demand Diels-Alder reaction (iEDDA), 
classified by the electron-poor diene (LUMO) reacting with the electron-rich 
dienophile (HOMO). The use of iEDDA for bioorthogonal reactions was first 
independently reported by Fox et al. and Devaraj [20a, 48]. The ligation of the electron 
deficient 1,2,4,5-tetrazine conjugated with trans-cyclooctene or norbornenes to 
generate the pyridanzine adducts [20b]. The iEDDA type is the most promising for 
bioorthogonal reactions with the advantages of proceeding within unusually fast 
reaction rates (k  1-105 M-1s-1) without employing any metal catalyst [49] and 
performing in various reaction media like water, organic solvents, cell media and cell 
lysates at ambient temperature. Recently, tetrazine moieties were investigated and 
applied as bioorthogonal tools for elucidating biological functions in living cells and 
live organisms [20a, b, 50]. 
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The prior results indicated that the magnitude of the reaction rate constant can be 
increased by the manipulation of electronic and steric effect on the tetrazine 
scaffolds. Firstly, the LUMO energy of the diene can be lowered by the introduction of 
heteroatoms (N or O) or by substitution of the electron-withdrawing group [49, 51]. 
Another possibility is to raise the HOMO energy of the dienophile by substitution with 
the electron-donating groups or increasing the ring strain on the system [52] (Figure 
6).  
 
 
 
Figure 6 Frontier orbitals in Inverse electron demand Diels-Alder reactions. 
 
Secondly, the steric demand on the tetrazine derivatives play an important role 
towards the dienophile partners, Kele et al. revealed that the introduction of steric 
hindrance substituents in close proximity to the reactive center play an important role 
towards the reactivity of the ligation. The results revealed that the reaction rate 
constant of the monosubstituted tetrazine compartments (k  240  10-3 M-1s-1) react 
approximately 30 times faster than that the disubstituted scaffolds (k  8  10-3 M-1s-1) 
[53]. Therefore the reactivity trend of the tetrazine scaffolds and the dienophile 
derivatives have been investigated by several research groups [52, 54] (Scheme 5). 
 
15 
 
 
 
Scheme 5 Structure and reactivity trend of the tetrazine scaffolds and the dienophile derivatives. 
 
Despite the reaction rate constant of the tetrazine ligation which was found to be 
extraordinarily fast (in fact, the fastest bioorthogonal reaction rate reported to date,     
k  1-105 M-1s-1) [52a, 54]. Conversely, due to the lack of stability toward the harsh 
conditions of chemical DNA synthesis along with the basic conditions for the 
cleavage step of the solid-phase, only a few examples of this labeling methodology 
were published. Wagenknecht et al., was the first to report the tetrazine-modified 
DNA for fluorescent labeling using phosphoramidite method [53]. The tetrazine-
modified 2’-deoxyuridine phosphoramidite was incorporated into DNA via automated 
solid-phase DNA synthesis and the corresponding DNA was then on-bead labeled 
with COMBO-modified fluorescein dye (Scheme 6A). Another approach was 
demonstrated by the group of Devaraj and co-workers [55]. The DNA bearing tetrazine 
moiety at the 5’-end was rapidly ligated with cyclopropene-modified DNA by the 
advances of DNA/RNA template-dependent ligation (Scheme 6B). 
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Scheme 6 A) On-bead postfluorescent labeling of tetrazine-modified DNA with cyclooctyne 
fluorescent dye, B) Template-dependent ligation of tetrazine-modified DNA with DNA bearing 
cyclopropane partner. 
 
An alternative strategy involves the introduction of dienophiles as DNA and RNA 
modifications that can later be postsynthetically labeled with tetrazine-modified dyes 
or biological compounds. The first example was evaluated by the Jäschke group [56] 
and others [57]. The dienophile-modified building blocks have been 
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incorporated into DNA or RNA at 5’-end or in the middle of strands, either via solid-
phase synthesis or primer extension using the polymerases. This novel strategy 
allows the further postsynthetic labeling with biological or fluorogenic compounds 
(Scheme 7). 
 
 
 
 
 
Scheme 7 A) iEDDA of the dienophile-modified RNA at the 5’-terminus with fluorescent tetrazine-
modified dyes. B) DNA and RNA bearing dienophile compartment for iEDDA reactions. 
Theorectical background 
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2.2.3 Strain-Promoted Azide-Alkyne Cycloaddition (SPAAC) 
 
The first discovery of a “copper-free click” reaction was reported in the 19th century by 
Blomquist and Lui [58]. Together with the results from Wittig and Krebs [59] which 
denoted that ring strained cyclooctynes underwent explosive [3+2] cycloaddition with 
phenylazide without employing a metal catalyst or high temperatures [58] to give a 
single product; the triazole. Since then, the concept of metal-free catalyzed azide-
alkyne cycloaddition has been developed and is well known as Strain-Promoted 
Azide-Alkyne Cycloaddition (SPAAC). It was the group of Bertozzi who first realized 
the potential of cycloalkynes as dipolarophiles towards azide moieties for 
bioorthogonal reactions for living cell imaging [15a, 60] (Figure 7).  
 
 
  
Figure 7 Strain-Promoted Azide-Alkyne Cycloaddition (SPAAC). 
 
Since the demonstration of the use of cyclooctyne in living cells, a number of 
applications of SPAAC as a tool to evaluate biological processes such as protein-
protein interactions [61], determining DNA modifications [62] and cell visualization in 
zebrafish [22b] and mice [7c] has been published in the last decade. According to prior 
reports the improvement of the cyclooctyne reactivity by mean, both the reaction rate 
constant and lipophilicity had been investigated by many research groups [60, 63]. 
However, the designs of new cyclooctynes which can react with a high reaction rate 
and have a high solubility in aqueous media are still difficult.  
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Many structural perturbations affecting more than one contributor to reactivity must 
be understood in order to be optimized to achieve the desired outcome. The major 
characteristics are steric effects (triple bond and azide moiety), the strain angle 
(distortion bond angle) and the electronic influence on transition state (orbital 
interaction). The empirical data and a DFT-based distortion/interaction transition state 
model of a set of 1,3-dipolar cycloadditions were investigated by Bertozzi and co-
workers [64]. The results show that the reactivity can be tunable and predictable by the 
advances of the relationship between the bond angles of substrates in the transition 
state and the overlap of their orbitals (Figure 8).  
 
A)      B)   C) 
 
 
 
 
 
 
Figure 8 Distortion/interaction model of 1,3-dipolar cycloaddition: A) activation energy (E
‡
) for the 
reaction between methyl azide and 2-butyne, B) azide and hexafluorobutyne, C) cyclooctyne and 
azide. 
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The distortion/interaction energy was calculated by using density functional theory 
(DFT) model and performed by using B3LYP/6-31G. In this calculation, the activation 
energy of a reaction was deconstructed into two components which are the distortion 
energy, that is dependent on ground state strain and the interaction energy which is 
governed by transition state electronics. In this model, the transition state energy 
(E‡) of a reaction is defined as the sum of distortion energies (E‡d), the energy 
required to distort the alkyne and azide into their preferred transition state 
conformations, and interaction energy (E‡i), the energy lowering upon favorable 
orbital overlap between the azide and alkyne (Equation (1)). 
 
    E‡ = E‡d + E
‡
i      (1) 
 
Thus, the reactivity of the cycloaddition can be tuned by changing either the distortion 
energy (E‡d) or the interaction energy (E
‡
i). The 1,3-dipolar cycloaddition of 2-
butyne, hexafluoro-2-butyne and cyclooctyne with methyl azide were selected as a 
model. In a case of 2-butyne with methyl azide, the results show that 29.9 kcal/mol 
energy is required to distort the ground state of substrates into the preferred 
transition state conformations. Upon distortion, the alkyne and azide interaction are 
lowering the energy of the overall system by -9.0 kcal/mol through favorable orbital 
overlapping. Combining the effects of distortion and interaction, the overall transition 
state activation energy is 20.9 kcal/mol (E‡ = E
‡
d +E
‡
i). In order to compare the 
electronic perturbation, it can affect the interaction and the distortion energies in the 
transition state. The activation energy for hexafluoro-2-butyne was investigated. The 
result showed that the overall activation energy (E‡) is 12.4 kcal/mol which was 8.5 
kcal/mol less than that in a case of 2-butyne which reveals that the hyperconjugative 
donation from the in-plane alkyne -system to the  C-F-orbital directly leads to 
transition state stabilization [65]. In a case of cyclooctyne moieties, the alkyne bond 
angles in cyclooctyne are already bent from linearity, and the molecule, therefore is 
destabilized relatively to a linear isomer.  
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Thus in the transition state, cyclooctyne requires less distortion energy to reach the 
preferred geometry than those of linear alkynes (E‡d, 2-butyne = 10.1 kcal/mol and 
E‡d, cyclooctyne = 2.1 kcal/mol). As a result of the significant reduction in distortion 
energy, cyclooctyne displays a lower overall activation energy than those of 2-butyne 
and hexafluoro-2-butyne substrates. According to the DFT-based 
distortion/interaction transition state model, numerous new ring strain cycloalkyne 
compounds were reported. In general, two classes of cyclooctyne’s can be 
recognized; aliphatic and (di)benzoannulated cyclooctynes with respect to a high 
reaction rate together with less lipophilicity (Scheme 8). 
 
 
 
Scheme 8 Structure of ring strained derivatives; dibenzocyclooctyne (DIBO), dibenzoazacyclooctyne 
(DIBAC), biarylazacyclooctynone (BARAC), difluorobenzocyclooctyne (DIFBO), difluorinated 
cyclooctyne (DIFO), bicyclo[6.1.0]nonyne (BCN), carboxymethylmonobenzocyclooctyne (COMBO) 
and tetramethylthiacycloheptyne (TMTH). 
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The high reaction rate constant can be achieved by dibenzoannulation on the 
cyclooctyne parent ring (dibenzocyclooctyne (DIBO) [7b]), by addition of 
sp2-hybridization of the ring parent (dibenzoazacyclooctyne (DIBAC) [66], 
biarylazacyclooctynone (BARAC) [64], (difluorobenzocyclooctyne (DIFBO) [67] or an 
introduction of an electron-withdrawing group (difluorinated cyclooctyne (DIFO) [68]), 
by the presence of fusion cyclopropane (bicyclo[6.1.0]nonyne (BCN) [7b]). The new 
generation of dipolarophiles which is more reactive was achieved by the introduction 
of sulfur atoms in the seven membered ring is tetramethylthiacycloheptyne (TMTH) 
[69] but it suffers from poor stability which cannot be separated in pure form before 
rapid decomposition takes place. With respecting to the reactivity and lipophilicity, the 
major drawback of high reaction rate constants of dibenzoannulated systems is high 
lipophilicity which is limits the scope of applications particularly in living systems 
when the reaction is required in aqueous media. Therefore, Kele et al., developed 
new structurally simple, non-fluorinated and less lipophilic molecules; 
carboxymethylmonobenzocyclooctyne (COMBO) [70]. In comparison with other 
cyclooctyne compounds COMBO shows an exceptional reaction rate constant (k = 
0.24 M-1s-1 in CD3CN and interestingly k = 0.80 M
-1s-1 in aqueous solution) together 
with low lipophilicity values which brings interest and more promise to evaluate this 
structurally simple molecule as a candidate reaction for cell labeling. It has been 
reported that SPAAC can be applied for postsynthetic modification of nucleic acid in 
order to overcome the toxicity of copper catalyst (CuAAC). To this end, an increasing 
number of new reactive building blocks for both DNA and RNA have been reported. 
Heaney and co-workers were the first who demonstrated the use of a resin-supported 
conjugation method for cyclooctyne-modified DNA at 5’-end which can be 
postsynthetically conjugated with not only azide components but also nitrile-oxides 
[71]. Later result from Filippov et al. revealed that the RNA bearing the reactive 
dibenzocyclooctyne on 5’-end was conjugated, proceeding quantitatively with the 
azide dyes and the biological compounds [63c, 72]. The same reactive 
dibenzocyclooctyne building block was also introduced into DNA at 5’ terminus for 
fast templated DNA strand ligations [73]. In order to extend the use of SPAAC in 
cellular delivery the development of a non-nucleosidic dibenzocyclooctyne building 
block was investigated by Manoharan and co-workers [74].  
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The results show that the monomer can be applied both at 3’-end and at an internal 
position in the RNA strands which was further reacted with azidoglyco derivatives 
(Scheme 9). 
 
 
 
Scheme 9 SPAAC of DNA and RNA bearing cyclooctyne derivatives with azido fluorescent dyes or 
biological compounds. 
 
Since then the exploration of SPAAC of nucleotide carrying cyclooctyne as reactive 
compartment towards azide derivatives have been intensively evaluated in the field of 
nucleic acid. The cyclooctyne-modified oligonucleosides have been introduced into 
DNA and RNA either via solid-phase synthesis or enzymatic DNA/RNA synthesis and 
the corresponding DNA/RNA bearing reactive group was quantitatively conjugated 
with azido boronic moieties [75], azido fluorescent dyes [63b, 76]. Recently, the 
application of SPAAC for far-red labeling of DNA was demonstrated by the group of 
Wagenknecht et al., where the monobenzocyclooctyne-modified DNA was smoothly 
“copper-free click” with the azide dye at room temperature to provide the desired 
DNA labeled in high yield [63d] (Scheme 10). 
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Scheme 10 Cyclooctyne-modified oligonucleoside building blocks for the fluorescent labeling in DNA 
and RNA for bioorthogonal reactions. 
 
Recent studies have shown that not only azides and strained cyclooctynes can 
undergo the strain-promoted reactions but also tetrazine scaffolds can rapidly 
proceed a Strain-Promoted Inverse Electron Demand Diels-Alder Cycloaddition 
(SPIEDAC) between strained dienophiles (trans-cyclooctene (TCO) or strained 
bicyclo[6.1.0]nonynes (BCN)) [49, 77]. As mentioned above tetrazines have the fastest 
reaction rate constant (k  1-105 M-1s-1) over those bioorthogonal reagents [52a, 54]. 
Unfortunately, the fastest reacting tetrazines are prone to hydrolysis [54b] and react 
with endogenous thiols [78], limiting their application in living cells [48, 50a, 78]. An 
alternative component which drawn the attention of many research groups are 
triazine scaffolds [51, 79]. Advantages over tetrazines are high stability (remained 
stable for over one week at 37 C in d-PBS and CD3CN) and inertness to cytosine 
over a similar time period, unless, it reacts slower (k = 10-3 M-1s-1).  
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Recently, Prescher et al. demonstrated the use of 1,2,4-triazines as a new class of 
bioorthogonal reagents which reacts efficiently and selectively with TCO but not with 
norbornene and cyclopropene [79a]. Additionally, these triazines can be attached to 
proteins via an amino acid linker and is sufficiently stable for genetic code expansion 
prior to subsequent tagging with TCO (Scheme 11).  
 
 
 
Scheme 11 A) Strain-Promoted Inverse Electron Demand Diels-Alder Cycloaddition (SPIEDAC) of 
tetrazine and stained dienophiles. B) The bioorthogonality of triazine scaffolds towards dienophiles 
and its application as bioorthogonal reactions.  
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Independently, Webb and co-workers [80] reported the cycloaddition of 1,2,4-triazine-
modified amino acids with strained bicyclononyne dienophiles, which are compatible 
with conventional peptide-synthesis strategies, which allows broad ranges of 
applications such as protein- and site-specific labeling in in vitro and in vivo, 
respectively (Scheme 12). 
 
 
 
Scheme 12 1,2,4-triazine-modified amino acid as new class of bioorthogonal reagent for protein-
labeling applications. 
 
To the best of my knowledge, the application of 1,2,4-triazine scaffolds are only 
demonstrated in amino acid modifications for protein-labeling, not in nucleic acids.  
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3  Results and Discussion 
 
3.1 Preparation of COMBO-modified oligonucleoside building blocks  
 
The COMBO acid 7 was achieved in 6 steps by the bromination of commercially 
available cyclooctadiene 1 to provide the precursor 2 in 79% yield, which was further 
partially eliminated HBr using tBuOK to obtain the intermediate 3 in 88% yield. The 
corresponding intermediate 3 was then coupled with methyl coumalate 4 using 18-
crown-6-ether and tBuOK to provide the key intermediate 5 in 38% yield. The 
corresponding intermediate 5 was treated with the same base in the presence of 18-
crown-6-ether at 58-60 C in the mixture solution of hexane and 1,4-dioxane (10:1) to 
generate the desired COMBO 6 in 38% yield. After treatment with LiOH followed by 
an acidic work-up the desired precursor COMBO acid 7 was obtained in 65% yield 
(Scheme 13). 
 
 
Scheme 13 Preparation of COMBO acid. 
Results and Discussion 
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Having COMBO acid 7 in hand, the COMBO-modified building block 14 was 
synthesized in 5 steps. The commercially available 5-iodo-2’-deoxyuridine (8) was 
first protected with DMTr at the 5’-position and subsequently coupled with 2,2,2-
trifluoro-N-prop-2-ynylacetamide (10) via a Sonogashira coupling. After deprotection 
of the TFA by concentration of NH3 the corresponding 5-(3’’-aminopropynyl)-2’-
deoxyuridine (12) was further coupled with COMBO acid 7 via standard peptide 
coupling to provide the desired intermediate 13 in 52% yield. The key intermediate 14 
was formed in 54% yield by the treatment of 13 with β-cyanoethyl-N,N-
diisopropylchlorophorsporamidite in the presence of DIPEA at room temperature. On 
the other hand, the propyl linker building block 19 was achieved in 5 steps. The 
Sonogashira coupling of 5-iodo-2’-deoxyuridine 8 with TFA-protected propagylamine 
10 was performed under the same conditions to obtain the intermediate 15 in 75% 
yield. Hence, the key step for achieving the precursor 19 was to reduce the propynyl 
linker of 15 to the alkyl linker of 16. This was done by the reduction of the propargylic 
moiety by using Pd(OH)2 on a carbon matrix in the presence of Et3SiH as the 
hydrogen source which yielded the crucial building block 16 in 70% yield. After 
protection of the 5’-OH group with DMTr moiety and cleavage of the TFA protecting 
group the corresponding compound 17 was further coupled with COMBO acid 7 via a 
standard peptide coupling method. Subsequently phosphitylation by reacting with                   
β-cyanoethyl-N,N-diisopropylchlorophorsporamidite under standard reaction 
conditions formed the desired product 19 in 90% yield (Scheme 14). 
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Scheme 14 Preparation of phosphoramidite COMBO-modified building blocks 14 and 19 as 
intermediated for automated solid-phase DNA synthesis. 
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3.2 Fluorescent labeling of COMBO-modified DNA 
 
The COMBO-modified DNA strands DNA1, 2, 5 and 6 were synthesized via standard 
automated solid-phase DNA synthesis (Figure 9). After cleavage from solid phase the 
corresponding products DNA1-DNA8 were subsequently purified by RP-HPLC, 
identified by MALDI-TOF mass spectrometry and quantified by UV/vis absorption 
spectroscopy. The fluorescent labeling of COMBO-modified DNAs with azido-
modified dye 21b were performed in the mixture of H2O-DMSO (10:1) at room 
temperature for 3 h. Surprisingly, the color of the azido-modified fluorescent dye 
turned from purple to light blue immediately after adding DNA to a mixture solution. It 
can be explained that the ligation of COMBO-modified DNA with dye 21b was rapidly 
occurred to generate the triazole covalently linked between the dye 21b and 
COMBO-DNA corresponding to the shift of the maxima absorption of the free azied-
modified dye 21b. After purifying the labeling adducts by RP-HPLC and 
characterization by MALDI-TOF, the labeled DNA products were obtained in 58% 
yield (DNA3), 63% yield (DNA4), 76% yield (DNA7) and 87% yield (DNA8). The 
labeled strands DNA3-DNA8 were hybridized with their unmodified complementary 
strands and their optical properties were evaluated by UV/vis and fluorescence 
spectroscopy. 
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Figure 9 Strain-Promoted Azide-Alkyne Cycloaddition (SPAAC) of COMBO-modified DNA with azide-
modified fluorescent dye 21b. 
 
3.2.1 Spectroscopic experiments 
 
The optical properties of DNA3-DNA8 were evaluated by UV/vis and fluorescence 
spectroscopy. The results showed that the maxima of absorption of the azide dye 
21b appeared in a bathochromic shift when conjugated with COMBO-modified DNA 
from 591 nm to 670 nm (DNA3), 612 nm (DNA4), 664 nm (DNA7) and 658 nm 
(DNA8), respectively. The fluorescence intensity dramatically increased in all cases 
and was found in a range of 8-14 folds higher than dye 21b itself. Additionally, the 
quantum yield values of the azide-modified labeled DNAs were also found higher 
than that the dye 21b alone (F = 1.64%, Table1). It could be explained that in the 
solution without interaction with DNA the two heterocycles have the possibility to 
rotate around their methane bridge which quenches fluorescence [81]. In contrast, the 
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triazole adduct covalently linked to DNA prohibits the rotation of the fluorescent dye 
together with the interaction of the surrounding nucleobases resulted in an increase 
in fluorescence intensity. The maxima of emission of the conjugated products were 
found slightly bathochromic shifted from 715 nm (21b) to 732 nm (DNA3), 730 nm 
(DNA4), 732 nm (DNA7) and 730 nm (DNA8), respectively (Figure 10).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 UV/Vis absorption (left), fluorescence (right) of ssDNA3 (2.5 M), ssDNA4 (2.5 M),  
ssDNA7 (2.5 M), and ssDNA8 (2.5 M), azide 21b (2.5 M), in comparison;                                                      
10 mM NaPi buffer, pH = 7, 250 mM NaCl, exc = 615 nm, maxima at em = 715 nm (21b),                 
em = 732 nm (ssDNA3), em = 730 nm (ssDNA4), em = 732 nm (ssDNA7), em = 730 nm (ssDNA8).
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In order to investigate the effect of the neighboring bases which are located adjacent 
to the fluorescent dye in DNA3 and DNA4 that contain the triple bond linker 
(nucleoside 14), and DNA7 and DNA8 that contain the flexible single bond linker 
(nucleoside 19) were hybridized with their unmodified complementary DNA strands. It 
was noteworthy that the fluorescence intensity was significantly decreased in both 
cases but still higher than the intensity of the free dye 21b itself. In the case of DNA3 
(in the vicinity of guanosine) and DNA4 (in the vicinity of thymidine) where the dye 
21b is linked via a triple bond, the fluorescence intensity of the double stranded DNA 
was found to have decreasing by 60% and 23% respectively compared to single 
strands. It was evident that the interaction of the fluorophore and nucleobase plays 
an important role to the fluorescence intensity of the dye. An explanation could be 
that in a double helix, guanosine has stronger H-bonding and - stacking 
interactions than thymine bases which influence the fluorophore 21b to rearrange to 
the preferable orientation, which means less steric and repulsion resulted in the low 
fluorescence intensity of DNA3 which is approximately 37% lower than that in DNA4 
(Figure 11).  
 
 
 
 
 
 
 
 
Figure 11 UV/Vis absorption (left), fluorescence (right) of ssDNA3 (2.5 M), ssDNA4 (2.5 M), azide 
21b (2.5 M), in comparison; 10 mM NaPi buffer, pH = 7, 250 mM NaCl, exc = 615 nm, maxima at em 
= 715 nm (21b), em = 732 nm (ssDNA3), em = 732 nm (dsDNA3), em = 730 nm (ssDNA4),              
em = 724 nm (dsDNA4).  
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Likewise, DNA7 and DNA8 that contain the flexible single bond linker (nucleoside 19) 
have shown similar characteristics. The decrease in the fluorescence intensity was 
60% (dsDNA7) and 20% (dsDNA8) in comparison to their corresponding single 
strands (Figure 12). 
 
 
 
 
 
  
 
Figure 12 UV/Vis Absorption (left), fluorescence (right) of ssDNA7 (2.5 M), ssDNA8 (2.5 M), azide 
21B (2.5 M), in comparison; 10 mM NaPi buffer, pH = 7, 250 mM NaCl, exc = 615 nm, maxima at  
em = 715 nm (21b), em = 732 nm (ssDNA7), em = 742 nm (dsDNA7), em = 730 nm (ssDNA8), em = 
722 nm (dsDNA8). 
 
Accordingly, prior results indicated that the interaction between the fluorophore and 
nucleobase could increase the fluorescence intensity by prohibiting the possibility of 
the rotation of the two heterocycles of fluorescent dye through the methane linker. In 
addition, the comparison of flexible linker and rigid bridge (surrounded by the same 
bases: guanosine) were also investigated. The comparison of the fluorescence 
characteristics of DNA3 and DNA7 indicated that the more flexible linker (DNA7) 
influences the interaction of fluorophore and nucleobases due to the increase in the 
fluorescence intensity (Figure 13).  
 
300 400 500 600 700 800
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8

A
/nm
 21b
 ssDNA7
 dsDNA7
 ssDNA8
 dsDNA8
650 700 750 800
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
I/
a
.u
.
/nm
 21b
 ssDNA7
 dsDNA7
 ssDNA8
 dsDNA8
 
35 
 
 
 
 
 
  
 
 
Figure 13 UV/Vis absorption (left), fluorescence (right) of ssDNA3 (2.5 M), ssDNA7 (2.5 M), azide 
21b (2.5 M), in comparison; 10 mM NaPi buffer, pH = 7, 250 mM NaCl, exc = 615 nm, maxima         
at em = 715 nm (21b), em = 732 nm (ssDNA3), em = 732 nm (dsDNA3), em = 730 nm (ssDNA7),     
em = 742 nm (dsDNA7). 
 
Therefore the comparison of the fluorescence characteristics of DNA4 and DNA8 
(surrounded by thymidine) were also evaluated. The results indicated that the propyl 
linker (DNA8), influences the interaction of the dye with DNA even more than the 
guanosine, as observed by the higher fluorescence intensity of DNA8 compared to 
DNA4 both in single and double stranded DNA (Figure 14). It could be explained that 
the flexible linker encourages the fluorophore to intercalate into double stranded DNA 
which prohibits the possibility of rotation of the fluorescent dye together with the - 
interaction of nucleobases towards the aromatic ring of the dye due to the increase in 
the fluorescence intensity. In contrast, when the rigid linker was present, the 
possibility of interaction with the nucleobases in DNA via - interaction was limited 
thus corresponding to the low fluorescence intensity observed. 
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Figure 14 UV/Vis Absorption (left), fluorescence (right) of ssDNA4 (2.5 M), ssDNA8 (2.5 M), azide 
21b (2.5 M), in comparison; 10 mM NaPi buffer, pH = 7, 250 mM NaCl, exc = 615 nm, maxima at em 
= 715 nm (21b), em = 732 nm (ssDNA4), em = 724 nm (dsDNA4), em = 730 nm (ssDNA8),             
em = 721 nm (dsDNA8). 
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The quantum yields of the single stranded DNA3-DNA8 and their corresponding 
double strands as well as the melting temperatures were measured. Table 1 
summarizes all optical properties. The results show that the quantum yields of the 
labeled DNA3-DNA8 showed a higher values than that the free dye 21b and the 
double stranded DNA were found to be slightly higher than that of the single stranded 
DNA in all cases. Interestingly, in the case of DNA8, the fluorescence shows the 
highest value of 13.2% corresponding to the previous results from fluorescence 
spectroscopy. Additionally, the melting temperatures of duplex DNAs were evaluated. 
In the case of DNA3 and DNA7, Tm values were found to be an astonishing 5.5 C 
lower than the unmodified duplex (66.5 C). Likewise DNA4 and DNA8 were 
decreased by 2.5 C and 1.5 C respectively, compared to unmodified reference 
duplex (59.5 C) [82]. It is evident, that the significant influence of the interaction of the 
fluorophore with the nucleic acids plays an important role to discriminate between 
hybridized strands. 
 
Table 1. Optical properties of fluorescent labeled oligonucleotides. 
 
DNA 
max, abs 
[nm] 
max, em 
[nm] F [%] T
m
 [°C] 
21b 591 715 1.64 - 
ssDNA3 670 732 9.2 - 
dsDNA3 682 732 9.4 61 
ssDNA7 664 732 9.8 - 
dsDNA7 680 742 10.0 61 
ssDNA4 612 730 8.7 - 
dsDNA4 657 729 9.4 54 
ssDNA8 658 730 8.6 - 
dsDNA8 654 721 13.2 53 
Results and Discussion 
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3.3  Fluorescent labeling in living cells 
 
Fluorescently tagged biomolecules have revolutionized the way in which scientists 
observe and investigate biological processes [2, 83]. The major advantages of this 
method are its high sensitivity tracking with excellent temporal and spatial resolution. 
There are several methods to selectively tag the biological target; (I) 
Immunofluorescence labeling which offers high selectivity and sensitivity by reducing 
non-specific background signals [2]. However, due to the limitation of their size which 
can only be applied to certain targets together with frequently observed photo 
bleaching phenomenon [2] had led to limit applications. (II) Genetically encoded 
fluorescent proteins (FPs) [84] can be used to tag proteins of interest in various colors 
such as green [84b], blue and yellow for example. This method offers a high sensitivity 
therefore concluding its non-toxicity to cells. However, a major problem in applying 
FPs methods in living organisms is their size (27 kDa). Regarding to this limitation, an 
alternative method is to introduce organic dyes which are less than 1 kDa in size into 
biomolecules. The latter method is the most promising strategy due to the 
manipulation of the fluorophores properties via simple chemical reactions. A third 
method, which allows the fluorescent tagging of biomolecules are bioorthogonal 
reactions (Figure 15). 
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Figure 15 Schematic living cell imaging methods: A) Immunofluorescent Technique, B) Genetically 
encoded fluorescent protein, C) Bioorthogonal conjugation. 
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3.3.1 Presynthetic fluorescent labeling in cells 
 
DNA2 and DNA6 were conjugated with the azido-modified dye 21b and purified by            
RP-HPLC. After identification by MALDI-TOF the oligonucleotides were hybridized 
with their unmodified complementary strands. These labeled double strands DNA 
were transfected into Hela cells by using Screenfect®A as a medium solution and 
subsequently visualized by confocal fluorescent microscopy (Figure 16).  
 
 
 
 
 
 
 
 
 
Figure 16 Images of Hela cells transfected with dsDNA4 and dsDNA8; left row fluorescence image, 
middle row: bright field image; right row: overlay of both images; bar indicate 10 µm. 
 
It is evident that the flexible linker of the covalently attached COMBO-triazole 
fluorophore on DNA plays an important role in enhancing the fluorescence intensity 
which was observed by the brightness of cell’s image of dsDNA8 in comparison with 
dsDNA4 from confocal fluorescence microscopy. This result tracks well with the 
previous experiments of fluorescence spectroscopy and quantum yield values. 
 
dsDNA4 
dsDNA8 10 µm 
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3.3.2 Postsynthetic fluorescent labeling in cells 
 
Regarding prior results, it is indicated that fluorescent tag of COMBO-modified DNA 
could be transfected into Hela cells without showing significant toxicity. Accordingly, 
the cells cytotoxicity was determined in order to investigate in vivo applicability of a 
set of azido-modified dyes 20a-22b. The standard method so called, CellTiter 96® 
Non-Radioactive Cell Proliferation Assay (Promega) was employed. The set of azido-
modified dyes 20a-22b were transfected into cells at different concentrations and 
incubated for 72 h. The negative control for 100% dead cells and positive control was 
included. After 72 h, all cell lines were treated with the tetrazolium salt solution and 
absorbance was measured at a wavelength of 595 nm. The results revealed that 
none of these azide-modified dyes shown significant toxicity in comparison to the 
control experiments (Figure 17).  
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Figure 17 Cell viability of Hela cell after treatment with azido-modified dyes 20a-22b. 
 
Therefore the next approach is to perform the “copper-free click” reaction inside the 
living cells. It is noteworthy that, DNA8 showed the most promising results by 
enhancing the fluorescence intensity. Therefore the single strand COMBO-modified 
DNA6 was chosen and transfected into Hela cells by using Screenfect®A as a 
medium solution prior to the ligation step. A set of azido-modified dyes 20a-22b were 
employed in order to investigate the effect of the polarity of the dyes of membrane-
permeability for future experiments. The results revealed that the transfected 
COMBO-modified DNA inside Hela cells could specifically conjugate with all dyes 
compared with the non-transfected control experiments without nonspecific 
fluorescence back ground that could originate from adsorption to the hydrophobic or 
negatively charged surface on DNA. Remarkably, the coumarin derivatives (21a, 
22a) showed specific DNA-tagged in the nuclei, while the benzo-furan dyes (21b, 
22b) were preferably taken up in endosomal vesicles (Figure 18).  
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Figure 18 In vivo click experiments of DNA6 and a set of azido fluorescence dyes 20a-22b; 1 × 10
4
 
Hela cells are transfected with ssDNA6 and subsequently incubated with dyes 20a-22b. Left columns: 
fluorescence confocal image; right columns: fluorescence image merged with bright field.                   
Scale bar 10 μm. 
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Remarkable results from the cell experiments showed that a set of fluorescent dyes 
20a-22b could be conjugated with COMBO-modified DNA6 inside living cells under 
physiological conditions, to provide the brightness in fluorescence and high selectivity 
that was observed compared with a non-transfected DNA experiment. The major 
advantage of this method is, that the reaction can proceed without requirement of 
metal catalysts or high temperatures with regard to a bioorthogonal reactions 
requirement. Moreover, the various types of azido-modified fluorescent dyes could be 
conjugated with COMBO-modified DNA in low concentrations under aqueous media 
conditions. To extend the advantage of using monobenzocyclooctyne (COMBO) as a 
bioorthogonal component candidate with other ring strained cyclooctynes for 
investigation and elucidation of the biological processes with respect to toxicity, 
reactivity and selectivity in biological systems the next approach was to employ the 
advantages of the polymerases for primer extension experiments. 
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3.4  Enzymatic DNA synthesis 
 
Since the 1950s, the modification of nucleosides bearing reactive moieties on 
nucleobases or their analogues have been tremendously investigated and applied in 
various fields such as chemical biology [85] and material science [86]. However, most of 
them are chemically synthesized via the advances of the phosphoramidite method on 
solid support [87]. Despite this method being facile, robust and scalable, the major 
drawbacks are (I) the difficulty of the synthesis of long nucleotides (100 NT), (II) the 
limitation of some functional groups which can react with phosphoramidites (prone to 
be oxidized by the phosphorus (III) atoms such as azide) and (III) the modified-
building blocks must be stable enough to survive the strong basic conditions of the 
cleavage step. An alternative method to incorporate modified-building blocks is to 
take (2’-deoxy)ribonucleotide triphosphates (dNTPs or NTPs) as substrates for 
enzymatic synthesis using the advantages of diverse polymerases to synthesize the 
DNA or RNA of interest from 5’3’ direction by the primer extension method (Figure 
19).  
 
 
 
 
 
Figure 19 Primer extension experiment (PEX) of modified-(2’-deoxy)ribonucleotide triphosphate 
building block in the presence of natural dNTPs catalyzed by a DNA polymerase. 
 
 
 
 
DNA polymerase,  
3 natural dNTPs 
dUTP 
3’ 5’ 
5’ 3’ 5’ 3’ 3’ 5’ 
Results and Discussion 
 
 
46 
 
The polymerase incorporates the upcoming nucleotide triphosphate at the 3’-end of 
the primer strand against the nascent base pair of the complementary template 
strand by the advances of Watson-Crick base pairing. If one or more of the natural 
dNTP(s) are replaced by modified building blocks, the polymerase incorporates the 
modified analogue in every position opposite to the complementary template strand. 
In this strategy, single or several modifications can be engineered by the change of 
the sequence of the template strand. This modified-nucleotide triphosphate building 
block can be incorporated either adjacent to each other or separated by a number of 
natural bases. Recently, the capability of DNA polymerases were revealed by Marx 
and co-workers [88]. The DNA polymerase accepts the base-modified nucleoside 
exclusively at C5 of pyrimidines and C7 of 7-deazapurines because those 
substituents are located in the major groove which does not affect the canonical base 
pairing. Moreover, the study showed that a more flexible linker could increase the 
efficiency of the incorporation due to the increase in hydrogen-bond capability. 
Additionally, the bulky modified building block, which could stabilize the growing 
primer of adjacent modification via - interaction, showed more efficient 
transformation [88-89]. The most promising DNA polymerases for primer extension of 
base-modified nucleotide building blocks are Themus aquaticus (Taq) namely, Klen 
Taq DNA polymerases classified as family A, Deep Vent and Vent are generally used 
when high temperatures are needed; those polymerases share the crucial activity of 
deficient 3’5’ exonuclease. Later studies indicated that the DNA polymerase family 
B which is thermo-stable, has a higher efficiency than the DNA polymerase family A; 
Thermococcus kodakarensis (KOD) and Pyrococcus furiosus (Pfu) for instance [88, 90]. 
The higher efficiency can be explained by the orientation of the reactive site of KOD 
polymerases where the extension proceeds above minor groove and therefore the 
upcoming modified-building block does not interact with the tip of the domain. In 
contrast, the corresponding area in family A is extended over the major groove where 
those substituents may clash the tip of domain (Figure 20). 
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Figure 20 The comparison of the DNA environments in family A and B DNA polymerases. A) Klen Taq 
DNA polymerase (PDB ID 3SZ2), B) KOD DNA polymerase (4K8Z) in binary complex 
[88]
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3.4.1 Preparation of the COMBO-modified 2’-deoxyuridine triphosphate 
building block 24 
 
To extend the advantages of SPAAC as a bioorthogonal tool for a fluorescent 
labeling in living cells the nucleotide triphosphates were prepared and incorporated 
into DNA by the advantage of the polymerases and subsequently conjugated with 
their reaction partners. One of the first methods for preparation of nucleotide 
triphosphates is the Yoshikawa method [91]. This procedure was carried out by 
reaction of unprotected nucleosides with phosphorus oxychloride and subsequent 
hydrolysis to obtain the monophosphate product (Scheme 15A) which can be further 
reacted with pyrophosphate to provide the desired nucleotide triphosphate in the final 
step. However the major drawback of using the Yoshikawa procedure is the 
competition of reactive hydroxyl group of the ribose-sugar to obtain a mixture of the 
undesired products. To overcome this problem Ludwig and Eckstein [92] reported a 
one-pot, 3-steps reaction developed in late 1980s (Scheme 15B). The reaction was 
carried out by using the chlorophosphate intermediate which was directly treated with 
pyrophosphate before hydrolysis. The corresponding cyclic triphosphate intermediate 
was then hydrolyzed in the presence of TEAB buffer in the final step. 
 
 
 
 
 
 
 
 
Scheme 15 Phosphorylation of base-modified nucleoside: A) Yoshikawa method, B) Ludwig-Eckstein 
method.
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The COMBO-modified 2’-deoxyuridine triphosphate 24 can be synthesized in 4 steps 
(Scheme 16). Precursor 23 was achieved by the standard method as mentioned 
above (Scheme 14) with 54% yield. Hence, the key step to achieve precursor 24 was 
the phosphorylation of the unprotected nucleoside building block 23 using the 
methodology of Ludwig et al. [92]. The reaction was carried out by treating the building 
block 23 with phosphorus oxychloride (POCl3) in the presence of trimethylphosphate 
and proton sponge at -5 C for 5 h yielding in a cyclic reactive triphosphate 
intermediate. This was rapidly treated with pyrophosphate and tributylamine at room 
temperature for 15 min. At this point the reaction mixture was slowly added to a 
TEAB buffer (pH = 7) at room temperature for 4 h and subsequently frozen and 
lyophilized. The crude product was then purified by RP-HPLC using a gradient of 
ACN-TEAB as eluent. The product-containing fractions were combined, freeze-dried 
and quantified by absorption spectroscopy at 260 nm which was obtained in 7% 
yield.  
 
 
 
Scheme 16 Preparation of COMBO-modified 2’-deoxyuridine triphosphate 24.  
 
Results and Discussion 
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3.4.2  Primer Extension Experiment (PEX) 
 
Evaluation of the capability to accept base-modified 2’-deoxynucleotides by different 
polymerases; Vent (exo-), Deep Vent (exo-), KOD XL and Homo Klen Taq were first 
investigated. It has been reported that the modification of pyrimidine nucleobases are 
favored at C5 and C7 of 7-deazapurine in order to avoid the disturbance of the 
Watson-Crick base pairing [88]. Vent (exo-), Deep Vent (exo-), Homo Klen Taq and 
KOD XL DNA polymerase were chosen for this experiment because their advantages 
are (I) deficiency of 3’5’-exonuclease activity which is suitable to employ base-
modified nucleoside triphosphates, and (II) the elongation reaction can be performed 
at high temperature which can accelerate the reaction rate of artificial nucleotide 
building blocks to that of natural triphosphate units (dNTPs). Primer extension 
experiments were performed by using primer P1 which contained fluorescein at the 
5’-terminus in order to follow the elongated product, by excitation wavelength of 
47120 nm and emission wavelength of 53520 nm on gels after electrophoresis. 
Template T1 was chosen as standing start experiment which means that the 
modified-building block is directly elongated after the cytidine natural nucleoside at 
the 3’-end terminus of primer. In addition, P2 and P3 were used as reference for the 
thymidine elongated product 24 NT (P2) and full length elongated product 35 NT (P3) 
in the presence of only natural nucleoside triphosphates, both of them are marked 
with fluorescein at 5’-end (Figure 21). 
 
 
 
Figure 21 Standing start experiment; template T1, primer P1, thymidine elongated product 24 NT 
reference (P2), full length elongated natural nucleoside triphosphate reference 35 NT (P3).
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The primer extension of the COMBO-modified 2’-deoxyuridine triphosphate 24 was 
performed at 72 C and catalyzed by the polymerases, Vent (exo-) and Deep Vent 
(exo-). In addition the negative experiment control was also performed in order to 
investigate their capability of accepting the artificial nucleotide triphosphate of the 
polymerase (Figure 22).  
 
 
 
 
 
 
 
 
 
 
Figure 22 PAGE analysis of standing start experiments of P1/T1 with Vent (exo-), Deep Vent (exo-) at 
72 C. 
 
The results from denaturing polyacrylamide gel electrophoresis (PAGE) indicated that 
the COMBO-modified nucleotide triphosphate 24 was accepted by the polymerases, 
which were evidenced by the fully elongated product after 30 min for Deep Vent 
(exo -) whereas Vent (exo-) was found to elongate incompletely even if the reaction 
time was extended to 90 min. In order to ensure the capability of the polymerase to 
accept the building block, a negative control experiment was conducted in parallel. It 
is evident that when only the COMBO-modified 2’ -deoxyuridine triphosphate 24 was 
added into a reaction mixture, the slower-moving band of the full length elongated 
products was missing.  
Results and Discussion 
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The standing start experiment of P1/T1 catalyzed by Hemo Klen Taq DNA 
polymerase was performed at 64 C. The results showed that the full length 
elongated product was observed after 30 min and the slower-moving band was 
missing when only the COMBO-modified triphosphate 24 was added into the reaction 
mixture. The difference of electrophoretic mobility on the gel in comparison to those 
of the reference primer P1 and full length elongated DNA P3 indicated that the 
COMBO-modified building block 24 was accepted by the polymerases with high 
efficient incorporation (Figure 23).  
 
 
 
 
 
 
 
 
Figure 23 PAGE analysis of standing start experiments of P1/T1 with Hemo Klen Taq at 64 C. 
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3.4.3  Postsynthetic fluorescent labeling of COMBO-modified DNA 
 
To extend the advances of the application of COMBO moiety as a bioothogonal 
component for fluorescent labeling of DNA, the “copper-free click” reaction with 
fluorescent dyes was investigated. The full length elongated product was treated with 
a tetrazine-modified rhodamine dye 25 under various reaction conditions in order to 
ensure the conjugation of bulky fluorophores with the lipophilic COMBO moiety. The 
conjugation was followed by PAGE analysis (Figure 24). 
 
 
 
 
 
 
 
 
 
Figure 24 PAGE analysis of the ligation of full length elongated DNA catalyzed by Hemo Klen Taq           
at 64 C with tetrazine-modified rhodamine dye 25 in aqueous media and a mixture of DMSO-H2O 
(10:1). Green indicates the fluorescence of fluorescein (exc = 47020 nm and em = 53520 nm).                
Red indicates the fluorescence of rhodamine (exc = 54010 nm and em = 60510 nm). 
Results and Discussion 
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It was hardly seen that the conjugated product was obtained regarding the result 
from PAGE analysis. As expected the slower-moving gel band on both channels 
(green and red) could be observed if the ligation step had occurred. It was hard to 
clarify that either the elongation was not successful or the “click” reaction was not 
accomplished. According to the result from “click” experiment, a significantly slower-
moving band of the conjugated product was not observed due to only a slightly red 
band in the rhodamine channel in PAGE analysis being obtained. It might be 
explained that the COMBO-modified nucleotide triphosphate was successfully 
incorporated. Nevertheless, the cyclooctyne reactive site seems to be orientated 
inside of the double helix in a way that sterically hinders the reactive site. The results 
revealed that the steric hindrance of the cyclooctyne plays an important role in the 
ligation efficiency. According to the result from the in vivo experiments, it was 
demonstrated that the single stranded COMBO-modified DNA6 could selectively 
ligate with the set of azied-modifid dyes 20a-22b under physiological conditions. To 
clarify this issue, the extension experiment was performed by elongating the building 
block into the 5’-terminal position. Primer P8 and template T3 were chosen for the 
terminal incorporation experiment at 5’-terminus where it was expected that the 
reactive moiety will orientate out of the double helix in order to be conjugated more 
efficiently by the fluorescent dye in aqueous media (Figure 25).  
 
 
 
Figure 25 5’-terminus incorporation experiment; template T3 obtained 24 NT, primer P8 obtained 18 
NT.  
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The incorporation of the COMBO-modified triphosphate 24 into DNA was first 
performed at 37 C and catalyzed by Hemo Klen Taq and KOD XL DNA polymerase 
in order to avoid the decomposition of the building block. The click step was 
performed under the same reaction conditions as the P1/T1 experiment. The 
elongation progress and ligated adduct were followed by PAGE analysis (Figure 26). 
The result from PAGE analysis showed that the incorporation of the COMBO-
modified triphosphate 24 at the 5’-terminus was successful after 90 min for Hemo 
Klen Taq, and 30 min for KOD XL DNA polymerase compared with the primer P8.  
 
 
 
 
 
 
 
 
 
 
Figure 26 PAGE analysis of 5’-terminus extension experiment; primer P8 catalyzed by Hemo Klen 
Taq and KOD XL DNA polymerase at 37 C. Green indicates the fluorescence of fluorescein           
(exc = 47020 nm and em = 53520 nm).  
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The full length oligonucleotide product was desalted, concentrated and dissolved in 
water to reach a final concentration of 750 nM. Subsequently, conjugation with either 
the tetrazine-modified rhodamine dye 25 or the azido-modified dye 26. The reaction 
was carried out in a mixture solution of DMSO-H2O (1:1) at room temperature for    
24 h. The reaction was directly applied to gel electrophoresis (Figure 27A). It can 
clearly be seen that no new slower-moving band was observed both in the green and 
the red channels. When having a closer look at the fluorescein channel, the 
elongated product, (which was dissolved in a mixture of DMSO-H2O (1:1)) showed 
the fragmentation of the extension product, which was not observed when only water 
was used as a solvent. It is noteworthy that DMSO could cause strand breaks in 
DNA. Regarding the results from PAGE analysis it is indicated that the elongated 
product of the COMBO-modified DNA was broken into 3 small DNA fragments which 
were 23 NT (breaking at elongated position of COMBO-modified building block), 
21/22 NT (adenosine or guanosine) and the slightly remained full length product (24 
NT) (Figure 27B). This result indicates that the DNA polymerases accepted the 
COMBO-modified 2’-deoxyuridine triphosphate as a new reactive building block but 
unfortunately the conjugation reaction conditions were not suitable to perform the 
“click” reaction in the presence of DMSO as a co-solvent. 
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      A) 
 
 
 
 
 
 
 
 
 
 
      B) 
 
 
Figure 27 A) PAGE analysis of the “click” reaction of full length elongated product (FP) with azide-
modified dye 26 and tetrazine-modified rhodamine dye 25 performed at room temperature in a mixture 
solution of DMSO-H2O (1:1), P8 primer. B) Full length elongated DNA and their possible strand break 
of DNA. 
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3.5  Preparation of the 1,2,4-triazine-modified 2’-deoxyuridine triphosphate 
building block 35 
 
The 1,2,4-triazine-modified 2’-deoxyuridine triphosphate building block 35 was 
synthesized in 6 steps. The key intermediate 3-carboxy-1,2,4-triazine (32) was 
achieved by the reaction of commercially available ethyl oxamate (27) and 
Lawesson’s reagent (28) to provide the reactive intermediate 29 which was 
subsequently treated with a 1 M solution of hydrazine in THF to obtain ethyl 
amino(hydrazo)acetate (30) in 62% yield. The ethyl-1,2,4-triazine-3-carboxylate (31) 
was obtained in 74% yield by the condensation reaction of 30 with 40% glyoxal in 
water solution, which was further treated with KOH followed by acidified with 1 N HCl 
to give the corresponding product 32 in 76% yield. The peptide coupling of 
aminopropyl-2’-deoxyuridine 33 with 3-carboxy-1,2,4-triazine (32) was then 
performed under standard reaction conditions, followed by phosphorylation of 34 
using the methodology of Ludwig et al. The crude product 35 was then purified by 
RP-HPLC using a gradient of ACN-TEAB as eluent. The product-containing fractions 
were combined, freeze-dried and quantified by absorption spectroscopy at 260 nm 
which gave a yield of 15% (Scheme 17). 
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Scheme 17 Preparation of 1,2,4-triazine-modified 2’-deoxyuridine triphosphate building block 35 
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3.5.1  Primer extension experiment and fluorescent labeling of 1,2,4-triazine-
modified DNA 
 
The investigation of the capability of DNA polymerases to accept the 1,2,4-triazine-
modified 2’-deoxyuridine triphosphate 35 was performed by using a variety of 
polymerases. Vent (exo-), Deep Vent (exo-), Homo Klen Taq and KOD XL DNA 
polymerase were chosen for this approach by their advances as mentioned above. 
The 1,2,4-triazine moiety was attached to the C5 position of 2’-deoxyuridine which 
was tolerated by all polymerases. Primer extension experiments were performed by 
using the primer P1; containing fluorescein at the 5’-terminus in order to follow the 
elongation product by following (exc = 47120 nm and em = 53520 nm) after gel 
electrophoresis. Template T1 was chosen as standing start experiment which means 
that the 1,2,4-triazine-modified triphosphate 35 will directly be incorporated after the 
cytidine natural triphosphate monomer at the 3’-end terminus of the primer. Template 
T4 was designed for double modification which means that the modified-building 
blocks are incorporated next to each other, template T5 for double modification and 
the modified-building blocks are incorporated separate from each other by 3 
nucleobases. Template T6 is for triple incorporation of modified-building blocks next 
to each other. In addition, P2 and P3 were used as reference for the thymidine; 
elongated product (24 NT) and full length elongation product in the presence of only 
natural nucleoside triphosphate (dNTPs) obtained 35 NT, respectively (Figure 28). 
 
 
 
Figure 28 Primer extension experiment; template T1, template T4 for double modification next to each 
other, template T5 for double modification separated by 3 bases, template T6 for triple modification 
next to each other, primer P1. 
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The incorporation of the 1,2,4-triazine-modified 2’-deoxyuridine was first investigated 
by using P1/T1 for standing start experiments catalyzed by KOD XL and Hemo Klen 
Taq DNA polymerase at 37 C. The results showed that the elongated product was 
observed. However, after 90 min the extension process was still not yet completed 
(Figure 29). It is noteworthy that at such a low temperature the DNA polymerase had 
a lower reactivity. Accordingly, the extension step was then investigated at a higher 
temperature, for instance at the maxima efficiency of the applied DNA polymerases. 
 
 
 
 
 
 
 
 
Figure 29 Standing start experiment of P1/T1 with KOD XL and Hemo Klen Taq DNA polymerase at 
37 C. 
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In this approach KOD XL DNA polymerase was chosen and the extension was 
performed at 64 C. The remarkable result from PAGE analysis indicated that the 
triazine-modified building block 35 was accepted by KOD XL which gave the desired 
extension product after 30 min as evidenced by the presence of a slower-moving 
band in comparison to primer P1 and the full length elongated primer P3 as 
reference. In addition, the negative control experiment was also investigated under 
the same reaction conditions. It can clearly be seen that the difference in gel mobility 
shows the absence of the full length elongated product (35 NT) which was observed 
when only 1,2,4-triazine-modified 2’-deoxyuridine triphosphate 35 was present in the 
reaction mixture (Figure 30). 
 
 
 
 
 
 
 
 
Figure 30 Standing start experiment of P1/T1 with KOD XL DNA polymerase at 64 C. 
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Moreover, a set of primer extension experiments were performed using various DNA 
polymerases at 64 C in order to further investigate the capability of DNA 
polymerases in accepting the 1,2,4-triazine-modified 2’-deoxyuridine triphosphate 35 
(Figure 31).  
 
 
 
 
 
 
 
 
 
Figure 31 Standing start experiment of P1/T1 with KOD XL, Hemo Klen Taq, Vent (exo-) and Deep 
Vent (exo-) DNA polymerase at 64 C.  
 
The elongated product was observed after 30 min in all cases which can clearly be 
seen from the difference of the electronegative mobility on the gel compared to P1, 
P2 and P3, respectively. The successful incorporation of the 1,2,4-triazine-modified 
building block 35 into DNA by using various DNA polymerases led to further 
investigation of the ability of this reactive probe for postfluorescent labeling of DNA. 
The reaction between 1,2,4-triazine-modified DNA with BCN-modified rhodamine 36 
was first performed in a mixture of H2O-DMSO (100:1) at room temperature without a 
desalting step. The conjugated product was elucidated by PAGE analysis.The result 
from the PAGE indicated that the conjugated product was obtained in 74% yield after 
treatment with BCN-modified rhodamine dye 36 at room temperature for 1 h in the 
presence of a 1000 equivalent of the dye 36. It was observed that when the dye 36 
was added another 1000 equivalent to the reaction mixture, the DA product was 
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obtained in the same yield 74%. In addition when the coupled step was extended to 
3 h in the presence of 1000 equivalent of BCN-modified rhodamine dye 36, the 
ligated product was still obtained in the same yield which was 74%, respectively 
(Figure 32).  
 
 
 
 
 
 
 
 
Figure 32 Diels-Alder reaction of the extension product (P1/T1) with BCN-modified rhodamine dye 36 
at room temperature in a mixture solution of H2O-DMSO (100:1) without desalted step. Green 
indicates the fluorescence of fluorescein, red indicates the fluorescence of rhodamine. 
 
Therefore, 1000 equivalent of BCN-modified rhodamine dye 36 will be used as a 
standard condition for other experiments. Regarding the prior experiments, that used 
a lower equivalent than 1000, the ligation step required a longer reaction time and/or 
the excess equivalent of the dye might affect the stability of DNA with respect the dye 
was dissolved in DMSO. Moreover, the conjugation product yield could be enhanced 
by an additional desalting step prior to the conjugation step. The primer extension 
experiments were conducted under the same reaction conditions subsequently, 
desalted, freeze-dried and dissolved in water to reach the final concentration of      
750 nM prior to the ligation steps. After treating with fluorescent dye 36 for 1 h the 
corresponding conjugated product was directly applied to PAGE. The results 
indicated that the efficiency of the Diels-Alder reaction had increased from 74% yield 
to 82% yield (Figure 33).   
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Figure 33 Diels-Alder reaction of the extension product (P1/T1) with BCN rhodamine dye 36 at room 
temperature for 3 h in a mixture solution of H2O-DMSO (100:1) after desalting step. 
 
The successful results from single labeling in DNA led to the investigation of the 
capability of multiple incorporations of the 1,2,4-triazine-modified building block 35 by 
using the advances of DNA polymerases. The primer extension experiment was 
conducted using the primer P1 with the templates; T4, T5 and T6, respectively. 
Regarding the elongation reaction from previous results, the modified building block 
35 was accepted at higher than 50 C. The extension reaction was first investigated 
at 55 C catalyzed by Deep Vent (exo-) DNA polymerase. It was obvious that the 
extension was completed after 60 min for the incorporation at adjacent positions 
P1/T4. On the other hand, when the modified building blocks were incorporated 
separate from each other by 3 bases, the results indicated that the Deep Vent (exo-) 
DNA polymerase tolerated the first incorporation but lacked efficiency to incorporate 
the next modified building block. Nevertheless, the full length product was observed 
after 30 min. As expected, the triple incorporation of modified building blocks 
adjacent to another is even more challenging. The results showed that after 60 min 
the extension product was obtained together with several shorten incomplete 
elongated DNA strands (Figure 34). An explanation could be that at a lower 
temperature, the efficiency of the DNA polymerase to accept the bulky modified-
building block was limited. As mentioned above, Deep Vent (exo-) DNA polymerase 
has its maximum activity at 72 C.  
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Figure 34 Primer extension experiments of double incorporation of modified-building blocks next to 
each other (P1/T4), double incorporation of modified-building blocks separated from each other by 3 
bases (P1/T5) and triple incorporation of modified-building blocks line next to each other (P1/T6) with 
Deep Vent (exo-) DNA polymerase at 55 C. 
 
In order to overcome this problem, the primer extension experiment was conducted 
at 72 C. The results from gel electrophoresis indicate that the extension was 
successful in obtaining the full length extension product after 90 min via incorporation 
adjacent to another and separate by 3 bases (P1/T4 and P1/T5) even though the 
truncated products were also observed. Surprisingly, the elongation of P1/T6 was not 
proceeding under this condition (Figure 35). It is noteworthy that compared to 
previous experiments, the Deep Vent (exo-) DNA polymerase accepted the triple 
incorporation at 55 C. It could be explained by the steric hindrance of 1,2,4-triazine-
modified 2’-deoxyuridine building blocks 35 which decreased the capability of the 
polymerase at higher temperatures.  
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Figure 35 Primer extension experiment of double incorporation of modified-building block adjacent to 
another (P1/T4), double incorporation of modified-building block separated from each other 3 bases 
(P1/T5) and triple incorporation of modified-building block adjacent next to another (P1/T6) with Deep 
Vent (exo-) DNA polymerase at 72 C. 
 
An alternative DNA polymerase for the extension experiments at moderate 
temperatures with high probability to accept the bulky modified-building block is KOD 
XL. The extension experiments with the modified building block, P1/T4, P1/T5 and 
P1/T6 were conducted at 64 C. The full length elongated product P1/T4 was 
observed after 90 min. Interestingly, the elongation by 1,2,4-triazine-modified building 
blocks 35 which were separated from each other by 3 bases P1/T5, remarkably 
showed the completed extension within 30 min. As mentioned above, the multiple 
incorporations of modified building blocks adjacent to each other are even more 
challenging. It could clearly be seen on the gel that the full length elongated product 
of P1/T6 was also obtained after 90 min. However, several shorter DNA strands as 
incomplete products were also obtained (Figure 36). 
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Figure 36 Primer extension experiments of double incorporation of modified-building blocks adjacent 
to another (P1/T4), double incorporation of modified-building blocks separated from each other by 3 
bases (P1/T5) and triple incorporation of modified-building blocks adjacent next to another (P1/T6) 
with KOD XL DNA polymerase at 64 C. 
 
After successful multiple incorporations of the 1,2,4-triazine-modified building block 
35 into DNA, the next step was to perform the Diels-Alder reaction (DA) with BCN-
modified rhodamine dye 36. The full length elongated product of P1/T4, P1/T5 and 
P1/T6 was desalted and freeze-dried prior to the conjugation reaction step. The 
crude product was then dissolved in water to reach the final concentration of 750 nM 
and subsequently mixed with BCN-modified rhodamine dye 36 (1000 fold) in a 
mixture of H2O-DMSO (100:1) at room temperature for 1 h and 3 h respectively. The 
visualization of PAGE analysis was performed by using exc = 47020 nm and em = 
53520 nm for fluorescein (green) and exc = 54010 nm and em = 60510 nm for 
rhodamine (red). It was clearly seen that the conjugation of 1,2,4-triazine-modified 
DNA, where the modified positions were adjacent to each other, T4 could be labeled 
by the DA reaction within 1 h and provided mixtures of single and double ligation 
products. Interestingly, after a 3 h reaction time, both the conjugated products were 
observed in 100% yield (Figure 37). 
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Figure 37 PAGE analysis of conjugation reaction of extension product P1/T4 in comparison with P1, 
P2, P3 and full length elongated product (FP). Green indicates the fluorescence emission of 
fluorescein (exc = 47020 nm and em = 53520 nm). Red indicates the fluorescence emission of 
rhodamine dye (exc = 54010 nm and em = 60510 nm). 
 
The conjugation of extension product P1/T5 with BCN-rhodamine dye 36 was 
performed under the same reaction conditions. PAGE analysis showed that the 
conjugation reaction proceeded even faster than that for P1/T4. The DA products 
were obtained in 100% yield within 1 h (Figure 38). It could be explained by the steric 
hindrance of the 1,2,4-triazine-moieties on DNA, when the incorporation into two 
adjacent positions inhibits the efficiency of the DA reaction and longer ligation times 
are necessary. In contrast, when the modification positions were separated from 
each other by 3 bases for P1/T5, less steric hindrance occurs, and the reaction can 
proceed faster. 
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Figure 38 PAGE analysis of conjugation reaction of extension product of P1/T5 in comparison with 
P1, P3 and full length elongated product (FP). Green indicates the fluorescence emission of 
fluorescein (exc = 47020 nm and em = 53520 nm). Red indicates the fluorescence emission of 
rhodamine dye (exc = 54010 nm and em = 60510 nm). 
 
The reaction with the extension product of P1/T6 was additionally performed. PAGE 
analysis showed that the conjugated product could be observed within 1 h to provide 
a mixture of single, double and triple labeled products in 65% total yield (Figure 39). 
The DA products and full length product (FP) were found to be destroyed if reaction 
times exceeded 3 h, which was indicated by the difference in gel electrophoretic 
mobility. The shortened fragment DNA strands were observed by the fluorescein 
channel (green) but not by the rhodamine channel (red), indicating that the breaking 
position is on the 5’-position of the full length product corresponding, the remained 
fluorescein tag-DNA stranded. It might be due to the presence of DMSO as a co-
solvent, as this causes DNA damage according to prior results (COMBO-modified 
DNA) where long reaction times were applied.  
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Figure 39 PAGE analysis of conjugation reaction of extension product of P1/T6 in comparison with 
P1, P3 and full length elongated product (FP). Green indicates the fluorescence emission of 
fluorescein (exc = 47020 nm and em = 53520 nm). Red indicates the fluorescence emission of 
rhodamine dye (exc = 54010 nm and em = 60510 nm). 
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4  Conclusions 
 
The postsynthetic labeling of base-modified oligonucleotides via strain-promoted 
reaction of reactive cyclooctyne- and triazine-modified nucleoside building blocks as 
a new class of bioorthogonal reactions were successful in both in vitro and in vivo 
experiments. The carboxymonobenzocyclooctyne (COMBO) moiety 7 was attached 
to 2’-deoxyuridine at C5-position via triple bond and single bond linkers with the 
purpose to investigate the influence of the rigid and flexible linkers on optical 
properties of modified-DNA. The incorporation of these bioorthogonally reactive 
moieties building blocks 14 and 19 into DNA was employed both by chemical DNA 
synthesis (phosphoramidite method) and enzymatic DNA synthesis (primer extension 
experiment with triphosphates). The copper-free click reaction of COMBO-modified 
DNAs with (E)-3-(6-azido-2-(2-(6-(diethylamino)benzofuran-2-yl)vinyl)benzo[d]thiazol-
3-ium-3-yl)propane-1-sulfonate (21b) was successful within 3 h to provide the desired 
clicked-oligonucleotide product in moderate to high yield (58-87% yield). As expected 
the more flexible linker enhanced the brightness of fluorescence both in single and 
double strands DNA. With respect to their high fluorescence intensity, DNA4 and 
DNA8 were chosen for presynthetic fluorescent labeling for in vivo experiments 
(Figure 40).  
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Figure 40 “Copper-free click” reaction of chemical incorporated COMBO-modified DNA with azido dye 
21b. 
 
The COMBO-modified DNA strands, DNA2 and DNA6 were conjugated with azide-
modified dye 21b at room temperature for 3 h. Subsequently the corresponding 
double strands dsDNA4 and dsDNA8 were transfected into Hela cells. Confocal 
fluorescence microscopy, visualized that the COMBO-modified DNA8 with the flexible 
linker provided higher fluorescence inside the cell compared to DNA4. According to 
its high fluorescence intensity inside cells, DNA6 was chosen for postfluorescent 
labeling in in vivo experiments. The COMBO-modified DNA6 was transfected prior to 
the ligation step. A set of azide-modified dyes 20a-22b, were employed in order to 
investigate the polarity influence for membrane-permeability. The COMBO-modified 
DNA6 was successfully conjugated with these azide-modified dyes inside cells to 
provide bright fluorescence. Remarkably, the results showed that the coumarin 
derivatives dye 20a and 21a were found in nuclei whereas the benzo-furan 
components 20b and 21b are preferably in endosomal vesicles (Figure 41). 
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Figure 41 Postsynthetic fluorescent labeling of COMBO-modified DNA in Hela cells. 
 
Unfortunately, the conjugation reactions of primer extension product (COMBO-
modified DNA) with fluorescent dyes were not successful. It may be explained by the 
high lipophilicity of the COMBO moiety that hide it inside the double strand, therefore 
the click reactions did not occur. To overcome this problem an alternative compound 
which exhibits less lipophilicity is 3-carboxy-1,2,4-triazine (32). The 1,2,4-triazine-
modified 2’-deoxyuridine triphosphate building block 35 was successfully prepared in 
high yield and subsequently incorporated into DNA via enzymatic DNA synthesis. 
The enzymatic incorporation of single and multiple positions was successful within 
30 min after optimization of the elongation condition (Figure 42). The conjugation of 
extension products with the BCN-modified dye 36 was performed at room 
temperature for 1-3 h. The ligated products were obtained in 82% yield for single 
incorporation P1/T1, in quantitative yield for a mixture of single and double DA 
products of P1/T4, in quantitative yield for a mixture of single and double DA products 
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of P1/T5 and 65% for the triple incorporation next to each other for P1/T6, 
respectively. 
 
 
 
 
 
 
 
 
Figure 42 Strain-promoted reactions of multiple incorporations of triazine-building blocks 35 with BCN-
modified fluorescent dye 36. 
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5  Experimental section 
 
5.1 Materials and methods 
 
Chemicals 
Chemicals, required for synthesis were purchased and were used without further 
purification from ABCR, Sigma Aldrich, Alfa Aesar, Acros, VWR and Fluka. The 
storage and handling took place according to the manufacturer's instructions. 
 
Solvent 
The solvents which were used for the synthesis were purchased from Acros, stored 
under argon atmosphere in the presence of molecular sieves. For work-up and 
purification, solvent of technical grade were used unless otherwise mentioned. The 
deuterated solvents for NMR measurement were purchased from euriso-top. 
 
Inert gas 
The reactions were carried out under an argon atmosphere (argon 4.6). The required 
glass wares were evacuated, heated with a heat gun and refilled cycle to ensure an 
inert atmosphere before adding the reagents.  
 
Ultrapure water 
Ultrapure water was generated by a Milli-Q® Direct 8/16 plant from Merck Millipore 
from tap water. 
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Thin layer chromatography (TLC) 
Aluminum TLC plates, coated with silica gel 60 and fluorescent indicator F254 with a 
layer thickness of 0.25 mm from Merck were used. The optical detection was carried 
out with a UV handheld lamp via fluorescence quenching at  = 254 nm or at  = 
366 nm. The analysis was carried out by staining either a solution of potassium 
permanganate (450 mg KMnO4, 630 mg K2CO3, 45 mL H2O, 750 μL 5% NaOH) or 
3% of H2SO4 in MeOH followed by heating with a hot-air drier. 
 
Flash Chromatography (FC) 
The silica gel technical grade (pore size of 60 Å and 230-400 mesh (40-63 μm) 
particle size) was purchased from Sigma Aldrich. The stationary phase was wet-
packed and the substance was either applied as solution (dissolved with a suitable 
solvent) or dried (adsorbed onto silica gel). The required overpressure was generated 
with a hand pump. The required eluents were mixed volumetrically in measuring 
cylinders. 
 
High performance liquid chromatography (HPLC) 
The purification of oligonucleotides and triphosphate building blocks were perform by 
using Reversed Phase Supelcosil™ LCC18 column (25 x 10 mm, 5 m for 
preparative separation) or a SupercosilTM LC-318 (25 cm × 4.6 mm, Supelcosil for 
analytical separation) on a Shimadzu HPLC system (autosampler SIL-10AD, pump 
LC-10AT, controller SCL-10A, diode array detector SPD-M10A) control by Class-VP 
software and degasser DGU-14A. The used flow rate was 1 ml/min (for analytical 
separation and 2.5 ml/min) or (for preparative separation). The elution; a gradient of 
acetonitrile (eluent B) and a 50 mM ammonium acetate buffer (pH = 6.5) in HPLC-
H2O (eluent A) was used for oligonucleotide purification. Triethylammonium 
bicarbonate buffer (eluent A, 50 mM, pH = 7) was used for the purification of 
triphosphates. The detection wavelength was selected at the maxima absorption 
which refers to the characteristic of molecules.  
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Table 2 Detection wavelength () of chromophore-modified DNA and fluorescent dye. 
 
Chromophores Detection wavelength () 
unmodified-DNA 260 nm 
COMBO 290 nm 
3-carboxy-1,2,4-triazine 320 nm 
21b 610 nm 
 
 
Lyophilisation 
For the sublimation drying, an Alpha 1-2 LD Plus lyophilization system from Christ 
was used. The samples were frozen in liquid nitrogen prior applied to lyophilization 
system. 
 
Solid-phase DNA synthesis 
Solid-phase DNA synthesis was conducted on an Expedite Nucleic Acid Synthesizer 
System from Applied Biosystems. The device was operated under an argon 
atmosphere as a protective gas. CPG (Controlled Pore Glass) with a coverage of 
1 mol (500 Å) served as a solid phase. The chemicals and CPG columns for solid 
phase synthesis were obtained from Applied Biosystems (ABI), Glen Research, 
Sigma Aldrich and Proligo Reagents.  
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Hybridization 
The hybridisation of single stranded DNA with their complementary strands were 
performed in the presence of 10 mM sodium phosphate buffer (NaPi, pH = 7) and 
250 mm NaCl at 90 C for 10 min and allowed to slowly cool down to room 
temperature.  
 
Thermocycler 
A thermal cycler used for primer extension experiments was used from 
biometra/Analytik Jena, model TGradient 96.  
 
Gel electrophoresis 
The denaturing polyacrylamide gels were freshly prepared by mixing 12% 
acrylamide/bisacrylamide (19:1), 15.5 ml of acrylamide/bisacrylamide (19:1, 40% 
aqueous dolution), 12.5 g of urea, 21 ml of 8.3 M of urea solution and 5 ml of 10 fold 
TBA buffer in the presence of 8.3 M urea solution (pH 8.0). The polymerization starts 
in the presence of 20 l of TEMED and 425 l of 10% APS solution. PAGE analysis 
was carried out under TBE buffer (2 mM EDTA, 89 mM TRIS base and 89 mM boric 
acid) as an electrolyte at 50 C, 45 W for 60 min using BioRad sequencing chamber 
(38 cm x 50 cm) and Sequi-Gen GT Sequencing Cell (21 cm x 40 cm) with a 
PowerPac HV from BioRad.  
 
Fluorescence Imager 
The visualization of the primer extension product was carried out with a Stella 8300 
fluorescence imager from Raytest. The emission was recorded with a full-frame CCD 
camera with microlenses (cooled to -20 °C). The excitation wavelength and a suitable 
emission filter were selected for each chromophore (exc = 47020 nm, and em = 
53520 nm; Cy2m, exc = 54010 nm, and em = 60510 nm; Cy3m and exc = 
63010 nm, and em = 70017.5 nm; Cy5m).  
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The exposure time varied between 2-6 min with maximum distance (Stage 4). The 
Aida Image Analyzer v.450 from Raytest was used to evaluate the images. 
 
Nanodrop ND-1000 Spectrophotometer 
The concentrations of synthesized oligonucleotides were determined by using the 
absorbance at 260 nm from peQlab.  
 
NMR measurements 
Nuclear magnetic resonance spectra were measured either on Bruker Avance 300, 
Avance 400 or Avance DRX 500 at Karlsruhe Institute of Technology (KIT), Institute 
of Organic Chemistry, in 0.5 ml deuterated solvents. The chemical shifts of the 
signals were reported in ppm based on tetramethylsilane as the zero point. The 
calibration was carried out via the signal of the incompletely deuterated solvent. In 
the case of 1H spectra or the solvent itself for 13C measurements [93]. 
 
 CDCl3:  
1H NMR: δ = 7.26 ppm  13C NMR: δ = 77.16 ppm 
 DMSO-d6:  
1H NMR: δ = 2.50 ppm  13C NMR: δ = 39.52 ppm 
 CD3OD:  
1H NMR: δ = 3.31 ppm  13C NMR: δ = 49.00 ppm 
 
The coupling constants (J) were given in Hz. The multiplicity of 1H signals has been 
abbreviated as follow: s (singlet), d (doublet), t (triplet), q (quartet), p (pentett), 
dd (doublet of doublet) and m (multiplet). 
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Mass spectrometry 
The mass spectra were recorded by the analytical department of the Institute of 
Organic Chemistry using Finnigan model MAT 95. The electron impact ionization (EI) 
and fast atom bombardment (FAB) were used for ionization techniques. MALDI mass 
spectra were recorded on a Biflex IV from Bruker Daltronics. The synthesized 
oligonucleotides were mixed with a 3-hydroxypicolinic (HPA) acid matrix and 
triphosphates in a 2’,4’,6’-trihydroxyacetophenone matrix (THAP). The data are given 
in m/z with the intensity as a percentage of the basic peak. 
 
Optical spectroscopy 
The optical measurements were carried out in quartz glass cuvettes from Starna. 
These were 1 cm in diameter and 1 ml in volume. The High Precision Cell Quartz 
Cells from Hellma were required when very small samples were measured (50 l with 
a light inlet of 3x3 mm).  
 
Absorption spectroscopy 
The absorption spectra were measured on a Cary 100 Bio Spectrometer from Varian 
with a temperature unit (Cary 100 temperature controller) at 20 °C. The spectra were 
background-corrected against the absorption of the pure solvent. The recording 
parameters used were: SBW: 2.0 nm; Average Time 0.1 s; Data Interval 1.0 as well 
as Light Source Changeover 350 nm and 390 nm, respectively. 
 
Fluorescence spectroscopy 
Fluorescence spectra were measured on a Horiba Jobin-Yvon Fluoromax-4-NIR 
fluorescence spectrometer. The samples were thermostated with a Peltier element 
LFI-3751 at 20 °C and the spectra were corrected based on the Raman dispersion of 
the solvent. The used settings were; increment 0.1 nm; increment time 0.2 s; 
excitation and emission bandpass of 5 nm. 
 
82 
 
Quantum yield measurement  
The quantum yields were determined on a Quantaurus QY C11347 from Hamamatsu 
in single mode by using excitation wavelength at 615 nm. 
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5.2  Synthesis 
 
Already literature known synthesis and spectroscopic data are not explicitly listed, but 
the corresponding literature references are given. 
 
7.2.1  Synthesis of COMBO-modified nucleoside building block 14  
 
2,2,2-trifluoro-N-prop-2-ynylacetamide (10) 
 
 
Ethyl trifluoroacetate (17.1 g, 120 mmol, 1.20 eq) was added dropwise into a cool 
solution of propargyl amine (5.51 g, 100 mmol, 1.00 eq) in MeOH at 0 C. The 
reaction was allowed to stir at room temperature overnight. After completion of the 
reaction, the mixture was neutralized by saturated NaHCO3 solution, extract with 
CH2Cl2 and dried over Na2SO4. The solvent was then removed under reduced 
pressure and the crude product was purified by column chromatography, CH2Cl2 
(100%) to obtain colorless oil 14.2 g (94.06 mmol) in 94% yield.  
TLC (CH2Cl2): Rf = 0.62 
The analytical data are consistent with the literature [94].  
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5’-O-4,4’-Dimethoxytrityl-5-iodo-2’-deoxyuridine (9) 
 
 
 
In a dried flask, 5-Iodo-2’-deoxyuridine (0.708 g, 2.00 mmol, 1.00 eq) and 4,4′-
dimethoxytriphenylmethyl chloride (1.02 g, 3.00 mmol, 1.50 eq) were dissolved in 
anhydrous pyridine (5 ml). To the solution mixture was then added Et3N (474 l, 3.40 
mmol, 1.70 eq) and stirred at 40 C for 18 h. After completion of the reaction, a 
solvent was removed under reduced pressure and the residue was purified by flash 
column chromatography (EtOAc-Hexane = 2:1+0.1% Et3N) to give a white solid 
0.968 g (1.50 mmol) in 74% yield. 
 
TLC (EtOAc-Hexane = 2:1+0.1% Et3N): Rf = 0.33 
The analytical data are consistent with the literature [95].  
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5-(3’’-aminopropynyl)-5’-O-dimethoxytrityl-2’-deoxyuridine (12) 
 
 
 
5’-DMT protected 5-Iodo-2’-deoxyuridine (0.180 g, 0.27 mmol, 1.00 eq), 
propargyltrifluoroacetamide (10) (0.123 g, 0.81 mmol, 3.00 eq), CuI (11.24 mg, 0.059 
mmol, 0.220 eq) and tetrakis-(triphenylphosphine) palladium (0) (31.2 mg, 0.030 
mmol, 0.01 eq) were dissolved in anhydrous DMF (5 ml). The mixture was degassed 
and anhydrous Et3N (76 l, 0.54 mmol, 2.0 eq) was added. The reaction mixture was 
allowed to stir at room temperature for 24 h. After completion of the reaction, the 
solution mixture was then filtered through celite, washed with EtOAc (10 ml). The 
solvent was removed under reduced pressure and the residue was then purified by 
flash column chromatography (CH2Cl2-Acetone = 5:1+0.1% Et3N) to give a light 
brown solid 0.079 g (0.120 mmol) in 72% yield. The corresponding adduct was then 
treated with 37% NH3 in aqueous solution at room temperature for 24 h. The desired 
light brown solid was obtained quantitative yield without further purification. 
 
TLC (CH2Cl2-MeOH = 10:1+0.1% Et3N): Rf = 0.13 
The analytical data are consistent with the literature [96].  
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2-methoxycarbonyl-5,6,9,10-tetrahydro-7,8-dehydro-benzocyclooctene (6) 
 
 
 
In a dried flask, KOtBu (210 mg, 1.87 mmol, 2.50 eq) and 18-cown-6-ether (50.0 mg, 
0.190 mmol, 0.250 eq) were placed. Then a mixture solution of hexane:1,4-dioxane 
(10:1, 100 ml) was added, the reaction mixture was heated up to 58 C at this point a 
solution of carboxymethylbromobenzocyclooctene (5) (220 mg, 75.0 mmol, 1.00 eq) 
in hexane:1,4-dioxane (10:1, 10 ml) was added dropwise and allow to stir at this 
temperature for 90 min. After completion of the reaction, the solid was then filtered 
off, washed with EtOAc (20 ml), a solvent was then removed under reduced 
pressure. The desired product was obtained after purification by column 
chromatography (Hexane-EtOAc = 10:1) to obtain a light yellow solid 60 mg 
(0.028 mmol) in 38% yield. 
 
TLC (hexane-EtOAc = 10:1): Rf = 0.42 
The analytical data are consistent with the literature [70].  
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5-[(3’’-COMBO-amino)prop-l-ynyl]-5’-O-dimethoxytrityl-2’-deoxyuridine (13) 
 
 
 
In dried flask, COMBO acid 7 (20 mg 0.09 mmol, 1.0 eq), 5-(3’’-aminopropynyl)-5’-O-
dimethoxytrityl-2’-deoxyuridine (12) (58 mg, 0.09 mmol, 1.0 eq), HBtU (32 mg, 0.09 
mmol, 0.094 eq) and HOBt (14.4 mg, 0.09 mmol, 1.0 eq) were placed. Anhydrous 
DMF (4 ml) was added into a reaction flask and allowed to stir under an argon 
atmosphere for 15 min. At this point, DIPEA (33 µl) was added and resulting mixture 
was allowed to stir at room temperature for another 2 h. After completion of the 
reaction, then a solvent was removed under reduced pressure and the residue was 
purified by gradient flash column chromatography (100% EtOAc, EtOAc-MeOH 
10:1+0.1 % Et3N) to give a light brown solid 36 mg (0.05 mmol) in 52% yield. 
 
TLC (EtOAc-MeOH = 10:1): Rf = 0.62 
The analytical data are consistent with the literature [63d]. 
 
 
 
 
 
88 
 
5-(3’’-COMBO-amino] prop-l-ynyl)-5’-O-dimethoxytrityl-2’-deoxyuridine-3-propyl 
diisopropylphosphoramidite (14) 
 
 
 
COMBO-modified 5-(3’’-aminopropynyl)-5’-O-dimethoxytrityl-2’-deoxyuridine (13) 
(36.0 mg, 0.05 mmol, 1.00 eq) was dissolved in anhydrous DCM (1.5 ml) at room 
temperature. To the resulting mixture was then added DIPEA (37.6 µl, 0.220 mmol, 
4.70 eq) and allowed to stir at room temperature under an argon atmosphere for 15 
min. At this point, β-cyanoethyl-N,N-diisopropylchlorophorsporamidite (25.2 µl, 
0.11  mmol, 2.40 eq) was added and the reaction mixture was allowed to continue for 
another 2 h. After completion of the reaction, a crude product was directly applied to 
flash column chromatography (DCM-Acetone = 10:3 +0.1%+ Et3N) to give a light 
yellow solid 25 mg (0.026 mmol) in 54% yield.  
 
TLC (EtOAc-MeOH = 10:1): Rf = 0.62 
 
HRMS (EI): m/z calcd for C55H61N5O9P1: 966.4201 [M+H]; found: 966.4200. 
 
31P-NMR (101 MHz, DMSO): δ (ppm) = 150.07. 
 
Experimental section 
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5.2.2  Synthesis of monobenzocyclooctyne nucleoside building block 19  
 
5-(3’’-aminopropynyl)-2’-deoxyuridine (15). 
 
 
 
In a dried flask, 5-Iodo-2’-deoxyuridine (8) (0.708 g, 2.00 mmol, 1.00 eq), 
propargyltrifluoroacetamide (10) (0.907 g, 6.0 mmol, 3.0 eq), CuI (83.8 mg, 
0.440 mmol, 0.220 eq) and tetrakis-(triphenylphosphine)-palladium(0) (231 mg, 
0.200 mmol, 0.01 eq) were placed and dissolved in anhydrous DMF (10 ml). The 
solution mixture was degassed followed by the addition of anhydrous Et3N (1.20 ml, 
8.00 mmol, 2.00 eq). The reaction mixture was allowed to stir at room temperature for 
24 h under an argon atmosphere. After completion of the reaction, a crude product 
was filtered through celite and washed with MeOH (20 ml). The solvent was then 
removed under reduced pressure, the light brown solid 0.562 g (1.50 mmol) in 75% 
yield was obtained after purified by flash column chromatography (CH2Cl2-MeOH, 
8:1).  
 
TLC (MeOH-CH2Cl2 = 8:1): Rf = 0.40 
 
1H-NMR (400 MHz, DMSO) : δ (ppm) = 10.11 (t, J = 5.6 Hz, 1H), 8.79 (s, 1H), 6.65 
(s, 1H), 6.14 (t, J = 6.1 Hz, 1H), 5.29 (d, J = 4.3 Hz, 1H), 5.11 (t, J = 5.3 Hz, 1H), 4.45 
(d, J = 4.6 Hz, 2H), 4.22 (dd, J = 5.9, 3.9 Hz, 1H), 3.92 (q, J = 3.8 Hz, 1H), 3.64 (qdd, 
J = 12.0, 5.3, 3.9 Hz, 2H), 2.40 (ddd, J = 13.4, 6.2, 4.1 Hz, 1H), 2.07 – 2.00 (m, 1H). 
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13C-NMR (101 MHz, DMSO) : δ (ppm) = 171.8, 158.4, 154.4, 152.6, 139.3, 121.3, 
106.2, 103.4, 88.9, 88.4, 70.3, 61.5, 41.9, 36.9. 
 
HRMS (EI): m/z calcd for C14H15N3O6F3: 378.0907 [M
+]; found: 378.0908. 
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5-3’’-[(trifluoroacetyl)amino] propyl-2’-deoxyuridine (16) 
 
 
 
To a dried flask, 5-(3’’-aminopropynyl)-2’-deoxyuridine (15) (200 mg 0.50 mmol, 
1.00  eq) was placed and dissolved in anhydrous MeOH (10 ml) under an argon 
atmosphere. Then Pd(OH)2 on carbon matrix (20% Wt, 10 mg) and triethylsilane 
(800  µl, 5.0 mmol, 10.0 eq) were added and the reaction mixture was allowed to stir 
at room temperature for 24 h. After completion of the reaction, the resulting mixture 
was filtered through celite and the filtrate was concentrated under reduced pressure. 
The residue was purified by flash column chromatography (CH2Cl2-MeOH = 10:1) to 
provide pale yellow solid 134 mg (0.35 mmol) in 70% yield. 
 
TLC (MeOH-CH2Cl2 =10:1): Rf = 0.22 
 
1H-NMR (400 MHz, DMSO) : δ (ppm) = 11.28 (s, 1H), 9.39 (t, J = 5.8 Hz, 1H), 7.66 
(s, 1H), 6.14 (t, J = 6.8 Hz, 1H), 5.21 (d, J = 4.2 Hz, 1H), 4.99 (t, J = 5.2 Hz, 1H), 4.26 
– 4.17 (m, 1H), 3.74 (q, J = 3.6 Hz, 1H), 3.60 – 3.48 (m, 2H), 3.15 (q, J = 7.0 Hz, 2H), 
2.18 (h, J = 8.1, 7.7 Hz, 2H), 2.12 – 2.00 (m, 2H), 1.69 – 1.56 (m, 2H). 
 
13C-NMR (101 MHz, DMSO) : δ (ppm) = 162.8, 155.6, 149.8, 135.9, 115.4, 112.1, 
86.8, 83.4, 69.9, 60.8, 39.1, 38.4, 26.6, 23.3. 
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HRMS (EI): m/z calcd for C14H18F3N3O6: 382.1220 [M+H]; found: 382.1219.  
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5-(3’’-amino propyl)-2’-deoxyuridine (33) 
 
 
 
To a flask, 5-3’’-(trifluoroacetyl) amino propyl-2’-deoxyuridine (16) (200 mg, 0.520 
mmol, 1.00 eq) was placed and 10 ml of concentrated NH3 was then added and 
allowed to stir at room temperature for 24 h. After completion of the reaction, the 
solvent was removed under reduced pressure to obtain the quantitative yield of the 
desired light brown solid as a product without a further purification step.  
 
1H-NMR (400 MHz, DMSO) : δ (ppm) = 11.34 (s, 1H), 7.75 (s, 1H), 7.66 (s, 2H), 6.19 
(t, J = 6.8 Hz, 1H), 5.29 (d, J = 4.2 Hz, 1H), 5.08 (s, 1H), 4.34 – 4.22 (m, 1H), 3.81 (q, 
J = 3.6 Hz, 1H), 3.60 (dd, J = 7.9, 3.8 Hz, 2H), 2.82 – 2.74 (m, 2H), 2.29 (t, J = 7.4 
Hz, 2H), 2.12 (dd, J = 6.8, 4.5 Hz, 2H), 1.81 – 1.67 (m, 2H). 
 
13C-NMR (101 MHz, DMSO) : δ (ppm) = 163.2, 150.1, 136.6, 112.0, 87.1, 83.8, 70.2, 
61.1, 39.3, 38.1, 25.9, 23.2. 
 
HRMS (EI): m/z calcd for C12H20N3O5: 286.1397 [M+H]; found: 286.1396. 
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5-(3’’-aminopropyl)-5’-O-dimethoxytrityl-2’-deoxyuridine (17) 
 
 
 
To the dried flask, 5-[3’’-(trifluoroacetyl) amino] propyl-2’-deoxyuridine (16) (230 mg, 
0.60 mmol, 1.00 eq) and dimethoxytrityl chloride (305 mg, 0.90 mmol, 1.50 eq) were 
placed, subsequently dissolved in anhydrous pyridine (2 ml) under an argon 
atmosphere. At this point, anhydrous Et3N was added and the reaction mixture was 
warmed up to 40 C and stirred at this temperature for 18 h. After completion of the 
reaction, the solvent was removed under reduced pressure, the crude product was 
then purified by column chromatography (CH2Cl2-MeOH = 100:3 + 0.1% Et3N) to 
provide yellow solid 403 mg (0.58 mmol) in 98% yield. The corresponding adduct was 
then treated with a concentrated NH3 overnight. The solvent was removed and the 
residue was lyophilized to obtain the desired product in quantitative yield without 
further purification. 
 
1H-NMR (500 MHz, DMSO) : δ (ppm) = 11.35 (s, 1H), 9.32 (t, J = 5.8 Hz, 1H), 7.39 
(s, 1H), 7.36 (d, J = 7.6 Hz, 2H), 7.28 (t, J = 7.6 Hz, 2H), 7.25 – 7.18 (m, 5H), 6.86 
(dd, J = 9.0, 2.3 Hz, 4H), 6.17 (t, J = 6.8 Hz, 1H), 5.30 (d, J = 4.6 Hz, 1H), 4.27 (dq, 
J = 8.3, 4.3 Hz, 1H), 3.88 – 3.81 (m, 1H), 3.71 (s, 6H), 3.22 – 3.10 (m, 2H), 2.95 (q, 
J = 6.9 Hz, 2H), 2.24 (dt, J = 13.7, 6.8 Hz, 1H), 2.17 – 2.05 (m, 1H), 1.88 (hept, 
J = 7.3, 6.7 Hz, 2H), 1.45 (dh, J = 13.0, 6.4 Hz, 2H). 
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13C-NMR (126 MHz, DMSO) : δ (ppm) = 163.0, 157.9, 156.0, 155.7, 150.1, 144.5, 
136.1, 135.2 (2C), 135.0 (2C), 129.5 (4C), 127.6 (2C), 127.5 (2C), 126.5, 116.9, 
114.6, 113.0, 112.7, 85.5, 85.2, 83.7, 70.3, 63.7, 54.8, 38.4, 27.2, 23.6. 
 
HRMS (EI) : m/z calcd for C33H37N3O7 : 588.2704 [M+H]; found : 588.2702. 
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5-[(3’’-COMBO-amino) prop-yl]-5’-O-dimethoxytrityl-2’-deoxyuridine (18) 
 
 
 
To a dried flask, 5-(3’’-aminopropynyl)-5’-O-dimethoxytrityl-2’-deoxyuridine (17) 
(58.0 mg, 0.09 mmol, 1.00 eq), COMBO acid (7) (20.0 mg, 0.09 mmol, 1.00 eq), 
HBtU (32.0 mg, 0.084 mmol, 0.94 eq), HOBt (14.4 mg, 0.09 mmol, 1.00 eq) were 
placed and dissolved with anhydrous DMF (4 ml). The reaction mixture was stirred 
under an argon atmosphere for 5 min, and then DIPEA (33 l) was added, the 
resulting mixture was allowed to stir at room temperature for 2 hours. After 
completion of the reaction, the solvent was removed under reduced pressure. The 
residue was subsequently purified by column chromatography (EtOAc-MeOH = 
9.5:0.5 + 0.1 % Et3N) to give a light yellow solid 52% yield. 
 
TLC (EtOAc-MeOH = 9.5:0.5 + 0.1 % Et3N): Rf = 0.50 
 
1H-NMR (400 MHz, DMSO) δ 11.38 (s, 1H), 8.30 (q, J = 5.8 Hz, 1H), 7.55 (s, 1H), 
7.47 (s, 1H), 7.38 (s, 1H), 7.36, (s, 2H), 7.34 – 7.23 (m, 7H), 6.87 (d, J = 8.3 Hz, 4H), 
6.21 (t, J = 6.8 Hz, 1H), 5.33 (d, J = 4.6 Hz, 1H), 4.31 (t, J = 5.6 Hz, 1H), 3.89 – 3.85 
(m, 1H), 3.70 (s, 6H), 3.28 – 3.13 (m, 2H), 3.15 – 3.02 (m, 5H), 2.58 – 2.55 (m, 2H), 
2.38 – 2.32 (m, 2H), 2.30 – 2.25 (m, 1H), 2.17– 2.13 (m, 1H), 2.04 – 1.89 (m, 2H), 
1.69 (s, 2H), 1.53 – 1.45 (m, 2H). 
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13C-NMR (100 MHz, DMSO) δ (ppm) = 166.1, 163.6, 158.3, 150.5, 145.0, 142.9, 
139.9, 139.7, 136.4, 135.7 (2C), 135.5 (2C), 133.4, 129.9, 129.4, 129.1, 128.6, 
128.1, 127.9, 126.9, 125.7, 113.6, 113.5, 85.9, 85.7, 84.1, 70.7, 64.4, 55.2, 49.1, 
45.9, 40.5, 38.5, 33.2, 32.9, 28.5, 27.7, 27.4, 24.2. 
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5-(3’’-COMBO-amino] prop-yl)-5’-O-dimethoxytrityl-2’-deoxyuridine-3-propyl 
diisopropylphosphoramidite (19) 
 
 
 
The COMBO-modified 5-(3’’-aminopropyl)-5’-O-dimethoxytrityl-2’-deoxyuridine (18) 
(60 mg, 0.08 mmol, 1.00 eq) was dissolved in anhydrous DCM (3 ml) at room 
temperature. To the resulting mixture was then added DIPEA (64.0 l, 0.370 mmol, 
4.70 eq) and allowed to stir at room temperature under an argon atmosphere for 15 
min. At this point, β-cyanoethyl-N,N-diisopropylchlorophorsporamidite (42.0 l, 
0.180  mmol, 2.40 eq) was added and the reaction mixture was allowed to continue 
for another 2 h. After completion of the reaction, a crude product was directly applied 
to flash column chromatography (DCM-Acetone = 5:2 + 0.1%+ Et3N) to give a light 
yellow solid 68 mg (0.07 mmol) in 90% yield.  
 
TLC (DCM-Acetone = 5:2 + 0.1%+ Et3N): Rf = 0.06 
 
FAB m/z (%) : 992.4 (50) (M+Na) 
 
31P-NMR (101 MHz, DMSO): δ (ppm) = 120.1. 
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5.2.3  Synthesis of monobenzocyclooctyne nucleotide triphosphate 24  
 
5-[(3’’-COMBO-amino)prop-yl]-2’-deoxyuridine (23) 
 
 
 
In a dried flask, aminopropyl-2’-deoxyuridine (33) (54.2 mg, 0.190 mmol, 1.10 eq), 
COMBO acid (7) (35 mg 0.17 mmol, 1.0 eq), HBtU (57 mg, 0.16 mmol, 0.94 eq) and 
HOBt (25.6 mg, 0.17 mmol, 1.0) were dried under reduced pressure then anhydrous 
DMF (2 ml) was added and the reaction mixture was stirred at room temperature for 
15 min. At this point, dried DIPEA (59 l) was added. The resulting mixture was 
allowed to stir under an argon atmosphere for another 2 hours. After completion of 
the reaction, a solvent was then removed and the crude product was purified by flash 
column chromatography (CH2Cl2-MeOH, 9:1) to give a light brown solid 43 mg 
(0.09  mmol) in 54% Yield. 
 
TLC (MeOH-CH2Cl2 =9:1): Rf = 0.53 
 
1H-NMR (400 MHz, DMSO) : δ (ppm) = 11.31 (s, 1H), 8.40 (t, J = 5.8 Hz, 1H), 7.73 
(s, 1H), 7.67 (s, 1H), 7.63 (dd, J = 7.8, 1.9 Hz, 1H), 7.27 (d, J = 8.0 Hz, 1H), 6.18 (t, J 
= 6.8 Hz, 1H), 5.24 (d, J = 4.2 Hz, 1H), 5.05 (t, J = 5.2 Hz, 1H), 4.25 (dq, J = 6.3, 3.2 
Hz, 1H), 3.77 (q, J = 3.7 Hz, 1H), 3.69 – 3.47 (m, 4H), 3.30 – 3.19 (m, 2H), 3.18 – 
3.06 (m, 2H), 2.29 – 2.01 (m, 8H), 1.68 (p, J = 6.9 Hz, 2H). 
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13C-NMR (101 MHz, DMSO) : δ (ppm) = 166.1, 163.4, 150.3, 144.3, 141.0, 136.4, 
132.8, 130.6, 129.6, 125.1, 113.0, 99.4, 99.3, 87.3, 83.9, 70.4, 61.3, 53.5, 41.8, 38.4, 
36.9, 36.6, 28.0, 23.9, 22.1. 
 
EI-MS m/z (%) = 468.1 (90) (M+H+)  
 
HRMS (EI): m/z calcd for C25H30N3O6: 468.2129 [M+H]; found: 468.2131. 
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5-[(3’’-COMBO-amino)prop-yl]-2’-deoxyuridine triphosphate (24) 
 
 
 
The COMBO-modified oligonucleoside 23 (20.0 mg, 0.042 mmol, 1.00 eq), proton 
sponge (grinded, 13.5 mg, 0.063 mmol, 1.50 eq) and a magnetic stirring bar were 
placed into the reaction flask and subsequently dried under vacuum overnight. Then 
TMP (29 l) was added and the reaction mixture was then cooled down to -5 C. At 
this point, POCl3 (4.1 l, 0.044 mmol, 1.05 eq) was then added to a solution via 
micropipette (one portion directly into the reaction mixture). The reaction was allowed 
to stir at -5 C for 4 h, another 0.4 eq (1.56 µl) of POCl3 was then added into a 
reaction mixture and allowed to stir for another 1 h. At this point, the solution of 
tributylammoniumpyrophosphate (139 mg, 0.252 mmol, 6.00 eq) and tributylamine 
(40 l) in dried DMF was added. After 15 min at -5 C the reaction mixture was 
transferred dropwise into a solution of 0.1 M TEAB over 45 min (1.0 ml per 0.016 
mmol of starting material; 4.0 ml). After stirring for 4 h at room temperature, the crude 
product was transferred into a falcon tube and freeze-dried under reduced pressure. 
The crude product was purified by RP-HPLC using gradient ACN-TEAB as eluent. 
The product-containing fractions were combined, freeze-dried and quantified by 
absorption spectrometry at 260 nm which was obtained in 7% yield. 
 
MALDI-MS : m/z (%) = 703.6 [MH+] 
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5.2.4  Synthesis of 5-[(3’’-1,2,4-triazine-amino)prop-yl]-2’-deoxyuridine (34) 
 
Ethyl amino(thioxo)acetate (29) 
 
 
 
Ethyl oxamate 27 (2.90 g, 50.0 mmol, 2.0 eq) and Lawesson’s reagent 28 (10.1 g, 
25.0 mmol, 1.00 eq) were placed into a reaction flask which was dried under vacuum 
under an argon atmosphere then dissolved in THF (100 ml). The mixture solution 
was refluxed for 2 h. After completion of the reaction, the resulting mixture was 
cooled to room temperature and 20 g of silica gel were added. The solvent was 
removed under reduced pressure. The residue was then purified by flash column 
chromatography (Hexane-EtOAc, 7:3) to give a light yellow solid 5.43 g (40.8 mmol) 
in 85% yield.  
 
TLC (Hexane-EtOAc = 7:3): Rf = 0.40 
 
1H-NMR (300 MHz, DMSO): δ (ppm) = 10.35 (s, 1H), 9.97 (s, 1H), 4.20 (qd, J = 7.1, 
0.8 Hz, 2H), 1.25 (td, J = 7.1, 0.8 Hz, 3H). 
 
13C-NMR (75 MHz, DMSO): δ (ppm) = 190.3 (s), 162.1 (s), 61.8 (s), 13.5 (s). 
 
EI-MS m/z (%) = 133.0 (100) (M+)  
Experimental section 
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Ethyl amino(hydrazono)acetate (30) 
 
 
 
To a dried reaction flask, ethyl amino(thioxo)acetate (29) (1.33 g, 10.0 mmol, 
1.00  eq) was placed and dissolved in degassed EtOH (20 ml). The red solution was 
stirred at room temperature for 10 min then a solution of 1 M solution of hydrazine in 
THF (10 ml, 10.0 mmol, 1.00 eq) was added dropwise over 30 min during which 
hydrogen sulfide was liberated. The reaction mixture was allowed to stir at room 
temperature for further 2.5 h. After completion of the reaction, the solvent was then 
removed under reduced pressure to obtain the yellow-red residue which was further 
recrystallized from Et2O-CH2Cl2 [50 ml, 4:1 (v/v)] to give a yellow solid 2.15 g 
(16.4  mmol) in 82% yield. 
 
TLC (7:3 Hexane-EtOAc): Rf = 0.40 
 
1H-NMR (300 MHz, DMSO): δ (ppm) = 5.69 (s, 2H), 5.35 (s, 2H), 4.13 (dt, J = 7.6, 
6.7 Hz, 2H), 1.21 (td, J = 7.1, 0.7 Hz, 3H). 
 
13C-NMR (75 MHz, DMSO): δ (ppm) = 162.7 (s), 135.6 (s), 60.7 (s), 14.3 (s). 
 
EI-MS m/z (%) = 131.1 (73) (M+) 
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Ethyl-1,2,4-triazine-3-carboxylate (31) 
 
 
 
The cooled mixture solution (-78 C) of ethyl amino(hydrazono)acetate (30) (2.62 g, 
20.0 mmol, 1.00 eq) and acetic acid (3 mL, 0.4 mmol, 0.02 eq) in THF (50 ml) was 
added into a cooled (-78 C) solution of 40% wt glyoxal in H2O (2.5 mL, 5.50 mmol, 
1.10 eq) in THF (50 ml) in one portion. The reaction mixture was then stirred for 
another 15 min at -78 C under an argon atmosphere. At this point, Et3N (4.2 mL, 
30.0 mmol, 1.5.0 eq) was then added, the cooling bath was removed and the 
reaction mixture was allowed to warm up to room temperature overnight. After 
completion of the reaction, the solvent was removed and a residue was purified by 
flash column chromatography (EtOAc-Hexane, 7:3) to give a light yellow solid 2.27 g 
(14.8 mmol) in 74% yield.  
 
TLC (7:3 EtOAc-Hexane): Rf = 0.51 
 
1H-NMR (400 MHz, DMSO): δ (ppm) = 9.62 (d, J = 2.5 Hz, 1H), 9.05 (d, J = 2.5 Hz, 
1H), 4.45 (q, J = 7.1 Hz, 2H), 1.37 (t, J = 7.1 Hz, 3H). 
 
13C-NMR (101 MHz, DMSO): δ (ppm) = 162.2 (s), 156.7 (s), 151.5 (s), 150.6 (s), 62.4 
(s), 13.9 (s).  
 
EI-MS m/z (%) = 153.1 (43) (M+)  
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3-carboxy-1,2,4-triazine (32) 
 
 
 
To a solution of Ethyl-1,2,4-triazine-3-carboxylate (31) (0.582 g, 3.80 mmol,1.00 eq) 
in dry EtOH (5 ml) was added a solution of KOH (0.235 g, 4.18 mmol, 1.10 eq) in dry 
EtOH (5 ml) over 40 min at room temperature. The resulting light brown suspension 
was then allowed to stir at room temperature for another 15 min, then the precipitate 
was filtered off, wash with EtOH (20 ml) and dried under reduce pressure. The 
corresponding light brown solid was then dissolved in 1N HCl (4.18 mL) and freeze-
dried overnight. The obtained mixture of potassium chloride and 1,2,4-triazine 
carboxylic acid was treated with water (10 ml) The resulting suspension was stirred 
for 40 min and filtered off, and washed with cold water. The desired light yellow solid 
was obtained 369.8 mg (2.90 mmol) in 76% yield. 
 
1H-NMR (300 MHz, DMSO): δ (ppm) = 9.58 (d, J = 2.5 Hz, 1H), 9.02 (d, J = 2.5 Hz, 
1H). 
 
13C-NMR (75 MHz, DMSO):δ (ppm) = 163.8 (s), 157.9 (s), 151.3 (s), 150.6 (s). 
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5-(1,2,4-triazine-3-carboxylate-amino] propyl}-2’-deoxyuridine (34) 
 
 
 
Aminopropyl-2’-deoxyuridine (33) (80 mg, 0.28 mmol, 1.0 eq), 3-carboxy-1,2,4-
triazine (32) (38.8 g, 0.31 mmol, 1.10 eq), HBtU (98.6 mg, 0.26 mmol, 0.94 eq) and 
HOBt (37.8 mg, 0.28 mmol, 1.00 eq) were placed in dried flask under an argon 
atmosphere. Anhydrous DMF (3 mL) was added and the resulting mixture was stirred 
at room temperature for 15 minutes. At this point, DIPEA (103 l, 0.56 mmol, 
2.20 eq) was added; the resulting mixture was stirred under argon atmosphere for 2 
hours. After completion of the reaction, the residue was directly applied to flash 
column chromatography. The light yellow solid was obtained by using 9:1 CH2Cl2-
MeOH as an eluent 50.2 mg (0.13 mmol) in 45% yield. 
 
TLC (9:1 CH2Cl2-MeOH): Rf = 0.2 
 
1H-NMR (400 MHz, DMSO): δ (ppm) = 11.30 (s, 1H), 9.57 (d, J = 2.5 Hz, 1H), 9.25 (t, 
J = 6.0 Hz, 1H), 9.02 (d, J = 2.5 Hz, 1H), 7.73 (s, 1H), 6.16 (dd, J = 7.6, 6.1 Hz, 1H), 
5.29 – 5.04 (bs, 2H), 4.24 (dt, J = 5.9, 3.1 Hz, 1H), 3.76 (q, J = 3.5 Hz, 1H), 3.63 – 
3.50 (m, 2H), 3.33 (q, J = 6.8 Hz, 2H), 2.33 – 2.19 (m, 2H), 2.18 – 2.01 (m, 2H), 1.72 
(p, J = 7.2 Hz, 2H). 
 
Experimental section 
 
 
107 
 
13C-NMR (101 MHz, DMSO): δ (ppm) = 164.1 (s), 161.9 (s), 158.6 (s), 151.7 (s), 
151.2 (s), 150.9 (s), 137.1 (s), 128.9 (s), 113.6 (s), 87.9 (s), 84.6 (s), 71.1 (s), 61.9 
(s), 39.3 (s), 28.4 (s), 24.5 (s). 
 
HRMS (EI): m/z calcd for C16H20N6O6: 393.1517 [M+H]; found: 393.1571. 
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5.2.5  Synthesis of 5-(1,2,4-triazine-3-carboxylate-amino] propyl}-2’-
deoxyuridine triphosphate (35) 
 
 
 
The triazine-modified oligonucleoside 34 (20.0 mg, 0.05 mmol, 1.00 eq), proton 
sponge (grinded, 16.1 mg, 0.075 mmol, 1.50 eq) and magnetic stirring bar were dried 
under vacuum overnight prior the reaction. TMP (290 µl) was added and the reaction 
mixture was cooled to -5 C. At this point, POCl3 (4.90 l, 0.053 mmol, 1.10 eq) was 
then added to a solution via micropipette (one portion directly into the reaction 
mixture). The reaction was allowed to stir at -5 C for 4 h then another 0.4 eq (1.9 l) 
of POCl3 was then added into a reaction mixture and allowed to stir at -5 C for 
another 1 h. At this point, the solution of tributylammoniumpyrophosphate (165 mg, 
0.3 mmol, 6.0 eq) and tributylamine (50 l) in dried DMF was added.                             
After 15 min at -5 C the reaction mixture was then added dropwise into a solution of 
0.1 M TEAB over 45 min (1.0 ml per 0.016 mmol starting material; 4 ml). After 4 h 
stirring at room temperature the crude product was transferred into a falcon tube and 
freeze-dried under reduced pressure. The crude product was purified by RP-HPLC 
using a gradient ACN-TEAB as eluent. The product-containing fractions were 
combined, freeze-dried and quantified by absorption spectrometry at 260 nm which 
was obtained in 15% yield. 
 
MALDI-MS : m/z (%) = 629.49 [MH+] 
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5.3 Solid-phase DNA synthesis 
 
5.3.1 Synthesis 
 
The automated solid-phase synthesis of the COMBO-modified DNA was carried out 
according to the phosphoramidite method on Expedite Nucleic Acid Synthesizer 
System from Applied Biosystems. The commercially available natural bases (A, C, T 
and G) were dissolved in acetonitrile (amidite diluent grade) and used as a 0.067 M 
solution for synthesis. The COMBO-modified phosphoramidites 14 and 19 were 
prepared as 0.1 M solution in abs. DCM prior the synthesis. For all oligonucleotides, 
the 5'-terminal DMTr protective group was removed (trityl-off synthesis) at the end of 
the synthesis. The following standard protocol was used for the incorporation of the 
building blocks of the natural bases A, G, C, T (Table 2). Other required reagent 
solutions are:  
 
Dblk (Deblock): 3% dichloroacetic acid in dichloromethane 
Wsh A (Wash A): acetonitrile 
Wsh (Wash): acetonitrile 
Act (Activator): 0.45 M tetrazole in acetonitrile 
Cap A: acetic anhydride in THF / pyridine 
Cap B: N-methylimidazole in THF / pyridine 
Ox (Oxidizer): iodine in water / THF / pyridine 
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Table 2: Standard protocol for coupling of the phosphoramidites of natural bases using the example of 
natural base A. Dblk = 3% dichloroacetic acid in CH2Cl2, Wsh = MeCN, Act = 0.45 M tetrazole in 
MeCN, Caps = Ac2O in THF / pyridine (Cap A) and N-methylimidazole in THF / pyridine (Cap B),      
Ox = iodine in water / THF / pyridine. 
 
Code function Mode amount time 
$ Deblocking     
144 Index Fract. Coll. NA 1 0 
0 Default WAIT 0 1.5 
141 Trityl Mon. 
On/Off 
NA 1 1 
16 Dblk PULSE 10 0 
16 Dblk PULSE 50 49 
38 Diverted Wsh A PULSE 40 0 
141 Trityl Mon. 
On/Off 
NA 0 1 
38 Diverted Wsh A PULSE 40 0 
144 Index Fract. Coll. NA 2 0 
$ Coupling     
1 Wsh PULSE 5 0 
2 Act PULSE 5 0 
21 A + Act PULSE 5 0 
21 A + Act PULSE 2 16 
2 Act PULSE 3 24 
1 Wsh PULSE 7 56 
1 Wsh PULSE 8 0 
$Capping     
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12 Wsh A PULSE 20 0 
13 Caps PULSE 8 0 
12 Wsh A PULSE 6 15 
13 Wsh A PULSE 14 0 
$Oxidizing     
15 Ox PULSE 15 0 
12 Wsh A PULSE 15 0 
$Capping     
13 Caps PULSE 7 0 
12 Wsh A PULSE 30 0 
 
The COMBO-modified 2’-deoxyuridine building blocks were incorporated into DNA 
using 1200 s for coupling step and the number of pulses required was increased to 
10.  
 
Table 3: Protocol for coupling of COMBO-modified phosphoramidite building blocks 14 and 19;               
6 = artificial nucleoside building blocks. 
 
Code Function Mode amount time 
$ Coupling     
1 Wsh PULSE 5 0 
2 Act PULSE 5 0 
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23 6 + Act PULSE 5 0  
23 6 + Act PULSE 5 600 
2 Act PULSE 5 400 
1 Wsh PULSE 7 200 
1 Wsh PULSE 8 0 
 
After completion of the synthesis, the CPG-filled columns were dried under vacuum 
overnight then the glass particles were transferred into an Eppendorf tube. 
Subsequently, 700 l conc. ammonia solution were added (> 25%, trace select, 
Fluka) and after mixing, the suspension was incubated for 24 h at 36 °C. Ammonia 
was then removed from the resulting mixture by centrifuge at 35 °C, 100 mbar for 
1 h. The supernatant was then separated from the residue by filtration. This was 
subsequently washed twice with in each case 300 l of HPLC water. The combined 
aqueous phases were lyophilized. The residue was then dissolved in 300 l of HPLC 
water and purified by RP-HPLC.  
 
5.3.2 Purification, characterization and concentration determination 
 
The purification of COMBO-modified DNA was carried out by RP-HPLC using a 
gradient of 50 mM ammonium acetate buffer (eluent A) and acetonitrile (eluent B). 
The detection wavelength at abs = 260 nm for COMBO-modified DNA and abs = 290 
nm for the COMBO moiety were used for characterization. The following conditions 
for the analysis and preparative separation of the COMBO-modified oligonucleotides 
were given. 
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Table 4 Gradient RP-HPLC and the detection wavelengths used for purification; A = 50 mM NH4OAc-
buffer (pH = 6.5), B = MeCN. 
 
COMBO-modified DNA Column Gradient Detection 
COMBO-DNA Supelcosil LC-318 0 – 25% B (50 min) abs = 260 nm, 290 nm 
COMBO-DNA + 21b Supelcosil LC-318 0 – 25% B (50 min) 
abs = 260 nm, 290 nm, 
610 nm 
 
The combined DNA-fractions were then characterized by MALDI-TOF mass 
spectrometry and the concentration was determined by measuring the absorbance at 
260 nm on ND 1000 spectrophotometer from Nanodrop. Nucleic Acids program was 
used to determine the absorbance at abs = 260 nm, Lambert-Beer’s law was applied. 
The extinction coefficient of unmodified DNA strand can be calculated by the 
following formula at 260 nm.  
260 = (A A + G G + T T + C C)*0.9 
 
A = number of adenine bases A = 15400 L(mol·cm)
-1  
G = number of guanine bases G = 11700 L(mol·cm)
-1 
T = number of thymine bases T = 8800 L(mol·cm)
-1 
C = number of cytosine bases C = 7300 L(mol·cm)
-1 
0.9 = factor to account for hypochromicity 
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The extinction coefficients of the artificial building blocks were determined prior 
incorporation and are listed: 
 
Table 5 Molar extinction coefficients of base-modified nucleoside building blocks. 
 
Artificial nucleosides 
Molar extinction coefficient 
[l/mol*cm
-1
] 
COMBO-building block 13 7930 
COMBO-building block 23 8900 
Triazine-building block 34 8523 
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5.3.3 Strain-Promoted Azide-Alkyne Cycloaddition 
 
DNA1, 2, 5 and 6 (10 nmol) were dissolved in 100 l of HPLC water. To this solution 
was then added 21.4 l (11 nmol) of a 514 M azide-modified dye 21b. The reaction 
mixture was shaken for 3 h at room temperature. After completion of the reaction, the 
residue was subsequently purified by RP-HPLC, characterized by MALDI-TOF mass 
spectrometry and quantified by absorption spectroscopy yielding the corresponding 
clicked product in 58% yield (DNA3), 63% yield (DNA4), 76% yield (DNA5) and 87% 
yield (DNA8), respectively.   
 
Table 6 SPAAC of COMBO-modified DNAs with azido fluorescent dye (21b) 
 
DNA Sequence 5´→3´ 
DNA1 5´-GCAGTCTG(dU14)GTCACTGA-3´ 
DNA3 5´-GCAGTCTG(dU14 + 21b)GTCACTGA-3´ 
DNA2 5´-GCAGTCTT(dU14)TTCACTGA-3´ 
DNA4 5´-GCAGTCTT(dU14 + 21b)TTCACTGA-3´ 
DNA5 5´-GCAGTCTG(dU19)GTTCACTGA-3´ 
DNA7 5´-GCAGTCTG(dU19 + 21b)GTCACTGA-3´ 
DNA6 5´-GCAGTCTT(dU19)TTCACTGA-3´ 
DNA8 5´-GCAGTCTT(dU19 + 21b)TTCACTGA-3´ 
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5.4  Enzymatic DNA synthesis 
 
5.4.1 Primer extension experiment (PEX) 
 
The primer extension experiments were carried out by using the primer P1 and a 
variation of template strands (T1, T4, T5 and T6). The reference strands P2 and P3 
were included for the better illustration of the observed bands. 
 
 
 
Figure 39 Primer; P1, templates; T1, T4, T5, and T6 and references; P2 and P3 for primer extension 
experiments. The primer and references are marked with fluorescein (Flu) at 5’-position. 
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The hybridization of primer and templates were carried out by using a thermocycler. 
First, primer and template were hybridized at 90 C for 10 min and allowed to cool 
down to room temperature in 1 h. At this point, the mixture solution of natural 
triphosphate building blocks and artificial triphosphate building block were added. 
After adding the polymerase the reaction mixture was elongated under the given 
temperature (altered from DNA polymerase). In order to ensure that all the reaction 
tubes have the same concentration, the reaction solution of primer and templates 
were prepared as a stock solution and given in each reaction tubes the same volume. 
The concentration of primer and templates for extension experiment, DNA 
polymerases and reaction conditions were listed. 
 
Table 7 The polymerases and the reaction condition for extension experiment 
 
Polymerases Reaction conditions (1X) 
Vent (exo-) 
Deep Vent (exo-) 
ThermoPol® Reaction Buffer:                                                
20 mM Tris-HCl, 10 mM (NH4)2SO4,10 mM KCl,                      
2 mM MgSO4, 0.1% Triton® X-100, pH 8.8 
Hemo Klen Taq 
Hemo Klen Taq reaction buffer:                                               
60 mM Tricine, 5 mM (NH4)2S04, 3.5 mM MgCl2, 6% glycerol, 
pH 8.7 
KOD XL KOD DNA Polymerase: pH 8.0 
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Table 8 The reaction condition for extension experiment 
 
Substances 20 l reaction scale 
Primer 750 nM (5 l) 
Template 900 nM (6 l) 
dATP, dCTP, dGTP, dU-triazineTP 100 nM (5 l) 
Buffer 4.0 l for Hemo Klen Taq/ 2.0 l for others 
DNA polymerase 0.25 l 
 
After completion of reaction, to the reaction mixture was added 20 l of loading buffer 
solution (20 mM EDTA (disodium salt), 89 mM TRIS base, 89 mM boric acid, 4% 
Ficoll, 0.1% bromphenol blue, 0.02% xylene cyanol FF, 7 M urea) the resulting 
mixture was directly applied to PAGE or an additional desalt step was applied. The 
reaction solutions were freed from salts by gel filtration through an illustra NAP-5 
column loaded with Sephadex G-25. The DNA was eluted according to the 
manufacturer's instructions, the DNA eluted with HPLC-H2O. The samples were then 
lyophilized, dissolved in HPLC-H2O to reach the final concentration of 750 nM were 
either directly mixed with loading buffer or used for ligation experiments. 
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5.4.2 Polyacrylamide gel electrophoresis (PAGE) 
 
The preparation of the denaturing polyacrylamide gel electrophoresis (PAGE); 12% 
was carried out by a mixture of 15.5 ml of acrylamide / bisacrylamide (19: 1, 40% 
aqueous solution), 12.5 g of urea, 21 ml of 8.3 M aqueous urea solution and 5 ml of 
10-fold concentrated TBE buffer (contained 8.3 M urea). The polymerization was 
performed by adding 20 l of TEMED and 425 l of a 10% APS solution to the 
mixture solution. After the casting, the gel was allowed to polymerize for 40 min. After 
completion, the gel was pre-heated by applying a voltage to the ideal separation 
temperature of 50 °C using 1-fold TBE buffer prior the application of the samples. 
The gel pockets of precipitated urea were purified by multiple washing with buffer 
solution subsequently 7 l of the sample was added into each gel pocket. The 
electrophoresis was carried out at 3000V and maximum 45 W for 1 h. The illustration 
was followed by fluorescence upon excitation at either 470 ± 20 nm with 
corresponding fluorescein emission at 535 ± 20 nm (Cy2 emission filter) or upon 
excitation of the dye fluorescence at 540 ± 10 nm and an emission filter of 605 ± 
20  nm (Cy3 emission filter). 
 
Table 9 The concentration of TBE buffer used for PAGE 
 
Substances Concentrations 
Tris 890 mM 
Boric acid 890 mM 
EDTA 20 mM 
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5.5 Click reaction of COMBO- and triazine-modified DNA with fluorescent 
dyes 
 
The click reactions of COMBO- and triazine-modified DNA with fluorescent dyes were 
performed at room temperature. After desalt and dissolved in HPLC water to reach 
the final concentration of 750 nM the solution was mixed with 1000-fold of fluorescent 
dyes. The reaction mixture was then shaken for 1-3 h at room temperature. After 
completion of the reaction, 20 l of loading buffer was added and the resulting 
solution was directly applied to PAGE. The corresponding clicked product was then 
illustrated compared with the mobility of references P1, P2 and P3, respectively. The 
yielding of clicked product was calculated by the integration of the fluorescence 
intensity of a slower-moving gel band compared with extension product band using 
the Aida Image Analyzer v.450 from Raytest. 
 
5.6. Cells experiments 
 
5.6.1 Pre-and postsynthetic fluorescent labeling in cells 
 
The DNA2 and DNA6 were conjugated with the azide-modified dye 21b in a mixture 
solution of H2O:DMSO (10:1) at room temperature for 3 h. After completion of the 
reaction, a solvent was removed and the crude product was dissolved in 300 l H2O 
subsequently purified by RP-HPLC. After identification by MALDI-TOF the 
corresponding DNA4 and DNA8 were hybridized with their unmodified 
complementary strands. These labeled DNA strands were transfected into Hela cells 
by using Screenfect®A as a medium solution. In the case of postsynthetic fluorescent 
labeling, the single strand DNA6 was transfected into Hela cells prior to the ligation 
step. The solution was rapidly mixed and incubated for 20 min at room temperature 
to allow the formation of the DNA-liposome complex. The transfection mixture was 
Experimental section 
 
 
121 
 
transferred to cells in each well of 8-well chambers slide ( Slide 8 well ibiTreat, 
IBIDI, Maetinsried, Germany).  
The cells were incubated at 37 C, 5% CO2 for 24 h which were washed with media 
and subsequently visualized by confocal fluorescence microscopy. 
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